Document and Entity Information
Document and Entity Information - shares | 9 Months Ended | |
Sep. 30, 2020 | Nov. 04, 2020 | |
Cover [Abstract] | ||
Entity Registrant Name | PERMA FIX ENVIRONMENTAL SERVICES INC | |
Entity Central Index Key | 0000891532 | |
Document Type | 10-Q | |
Document Period End Date | Sep. 30, 2020 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --12-31 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business Flag | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 12,153,897 | |
Document Fiscal Period Focus | Q3 | |
Document Fiscal Year Focus | 2020 |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Sep. 30, 2020 | Dec. 31, 2019 | |
Current assets: | |||
Cash | $ 4,811 | $ 390 | |
Accounts receivable, net of allowance for doubtful accounts of $432 and $487, respectively | 13,442 | 13,178 | |
Unbilled receivables | 14,366 | 7,984 | |
Inventories | 525 | 487 | |
Prepaid and other assets | 3,863 | 2,983 | |
Current assets related to discontinued operations | 17 | 104 | |
Total current assets | 37,024 | 25,126 | |
Property and equipment: | |||
Buildings and land | 20,049 | 19,967 | |
Equipment | 22,285 | 20,068 | |
Vehicles | 456 | 410 | |
Leasehold improvements | 23 | 23 | |
Office furniture and equipment | 1,470 | 1,418 | |
Construction-in-progress | 1,513 | 1,609 | |
Total property and equipment | 45,796 | 43,495 | |
Less accumulated depreciation | (27,900) | (26,919) | |
Net property and equipment | 17,896 | 16,576 | |
Property and equipment related to discontinued operations | 81 | 81 | |
Operating lease right-of-use assets | 2,353 | 2,545 | |
Intangibles and other long term assets: | |||
Permits | 8,875 | 8,790 | |
Other intangible assets - net | 923 | 1,065 | |
Finite risk sinking fund (restricted cash) | 11,418 | 11,307 | |
Other assets | 911 | 989 | |
Other assets related to discontinued operations | 36 | ||
Total assets | 79,481 | 66,515 | |
Current liabilities: | |||
Accounts payable | 14,652 | 9,277 | |
Accrued expenses | 6,743 | 6,118 | |
Disposal/transportation accrual | 1,041 | 1,156 | |
Deferred revenue | 4,806 | 5,456 | |
Accrued closure costs - current | 75 | 84 | |
Current portion of long-term debt | [1] | 828 | 1,300 |
Current portion of operating lease liabilities | 265 | 244 | |
Current portion of finance lease liabilities | 675 | 471 | |
Current liabilities related to discontinued operations | 919 | 994 | |
Total current liabilities | 30,004 | 25,100 | |
Accrued closure costs | 6,207 | 5,957 | |
Deferred tax liabilities | 588 | 590 | |
Long-term debt, less current portion | 6,426 | 2,580 | |
Long-term operating lease liabilities, less current portion | 2,141 | 2,342 | |
Long-term finance lease liabilities, less current portion | 715 | 466 | |
Other long-term liabilities | 838 | ||
Long-term liabilities related to discontinued operations | 250 | 244 | |
Total long-term liabilities | 17,165 | 12,179 | |
Total liabilities | 47,169 | 37,279 | |
Commitments and Contingencies (Note 10) | |||
Stockholders' Equity: | |||
Preferred Stock, $.001 par value; 2,000,000 shares authorized, no shares issued and outstanding | |||
Common Stock, $.001 par value; 30,000,000 shares authorized; 12,152,363 and 12,123,520 shares issued, respectively; 12,144,721 and 12,115,878 shares outstanding, respectively | 12 | 12 | |
Additional paid-in capital | 108,790 | 108,457 | |
Accumulated deficit | (74,445) | (77,315) | |
Accumulated other comprehensive loss | (251) | (211) | |
Less Common Stock in treasury, at cost; 7,642 shares | (88) | (88) | |
Total Perma-Fix Environmental Services, Inc. stockholders' equity | 34,018 | 30,855 | |
Non-controlling interest | (1,706) | (1,619) | |
Total stockholders' equity | 32,312 | 29,236 | |
Total liabilities and stockholders' equity | $ 79,481 | $ 66,515 | |
[1] | Net of debt discount/debt issuance costs of ($99,000) and ($248,000) at September 30, 2020 and December 31, 2019, respectively. The Promissory Note provides for prepayment of principal over the term of the Note without penalty. In 2019, the Company made total prepayment of principal of $520,000 which was reflected in the current portion of the debt. During the first nine months of 2020, the Company made total principal repayment of $1,457,000 of which $416,000 was prepaid. At September 30, 2020, outstanding balance of the loan are current. |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands | Sep. 30, 2020 | Dec. 31, 2019 |
Statement of Financial Position [Abstract] | ||
Accounts receivable, allowance for doubtful accounts | $ 432 | $ 487 |
Preferred stock, par value | $ 0.001 | $ 0.001 |
Preferred stock, shares authorized | 2,000,000 | 2,000,000 |
Preferred stock, shares issued | ||
Preferred stock, shares outstanding | ||
Common stock, par value | $ 0.001 | $ .001 |
Common stock, shares authorized | 30,000,000 | 30,000,000 |
Common stock, shares issued | 12,152,363 | 12,123,520 |
Common stock, shares outstanding | 12,144,721 | 12,115,878 |
Treasury stock, shares | 7,642 | 7,642 |
Consolidated Statements of Oper
Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Income Statement [Abstract] | ||||
Net revenues | $ 30,172 | $ 22,535 | $ 77,079 | $ 51,378 |
Cost of goods sold | 25,422 | 17,378 | 64,379 | 40,449 |
Gross profit | 4,750 | 5,157 | 12,700 | 10,929 |
Selling, general and administrative expenses | 3,308 | 2,945 | 8,935 | 8,548 |
Research and development | 157 | 165 | 598 | 615 |
Loss on disposal of property and equipment | 4 | 27 | 3 | |
Income from operations | 1,285 | 2,043 | 3,140 | 1,763 |
Other income (expense): | ||||
Interest income | 28 | 77 | 112 | 265 |
Interest expense | (87) | (99) | (306) | (293) |
Interest expense-financing fees | (58) | (69) | (187) | (139) |
Other | 180 | (2) | 189 | 222 |
Loss on debt extinguishment of debt | (27) | |||
Income from continuing operations before taxes | 1,348 | 1,950 | 2,921 | 1,818 |
Income tax (benefit) expense | (133) | 55 | (128) | 99 |
Income from continuing operations, net of taxes | 1,481 | 1,895 | 3,049 | 1,719 |
Loss from discontinued operations, net of taxes of $0 | (67) | (156) | (266) | (424) |
Net income | 1,414 | 1,739 | 2,783 | 1,295 |
Net loss attributable to non-controlling interest | (32) | (29) | (87) | (90) |
Net income attributable to Perma-Fix Environmental Services, Inc. common stockholders | $ 1,446 | $ 1,768 | $ 2,870 | $ 1,385 |
Net income (loss) per common share attributable to Perma-Fix Environmental Services, Inc. stockholders - basic: | ||||
Continuing operations | $ 0.13 | $ 0.16 | $ 0.26 | $ 0.15 |
Discontinued operations | (0.01) | (0.01) | (0.02) | (0.03) |
Net income per common share | 0.12 | 0.15 | 0.24 | 0.12 |
Net income (loss) per common share attributable to Perma-Fix Environmental Services, Inc. stockholders - diluted: | ||||
Continuing operations | .13 | .16 | .25 | .15 |
Discontinued operations | (.01) | (.01) | (.02) | (.04) |
Net income per common share | $ .12 | $ .15 | $ .23 | $ .11 |
Number of common shares used in computing net income per share: | ||||
Basic | 12,145 | 12,070 | 12,134 | 12,029 |
Diluted | 12,371 | 12,123 | 12,337 | 12,061 |
Consolidated Statements of Op_2
Consolidated Statements of Operations (Unaudited) (Parenthetical) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Income Statement [Abstract] | ||||
Loss from discontinued operations, tax | $ 0 | $ 0 | $ 0 | $ 0 |
Consolidated Statements of Comp
Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Statement of Comprehensive Income [Abstract] | ||||
Net income | $ 1,414 | $ 1,739 | $ 2,783 | $ 1,295 |
Other comprehensive income (loss): | ||||
Foreign currency translation adjustment | 11 | 4 | (40) | 12 |
Comprehensive income | 1,425 | 1,743 | 2,743 | 1,307 |
Comprehensive loss attributable to non-controlling interest | (32) | (29) | (87) | (90) |
Comprehensive income attributable to Perma-Fix Environmental Services, Inc. stockholders | $ 1,457 | $ 1,772 | $ 2,830 | $ 1,397 |
Consolidated Statement of Stock
Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands | Common Stock [Member] | Additional Paid-In Capital [Member] | Common Stock Held In Treasury [Member] | Accumulated Other Comprehensive Loss [Member] | Non-controlling Interest in Subsidiary [Member] | Accumulated Deficit [Member] | Total |
Balance at Dec. 31, 2018 | $ 12 | $ 107,548 | $ (88) | $ (214) | $ (1,495) | $ (79,630) | $ 26,133 |
Balance, shares at Dec. 31, 2018 | 11,944,215 | ||||||
Net Income (loss) | (30) | (672) | (702) | ||||
Foreign currency translation | 12 | 12 | |||||
Issuance of Common Stock for services | 60 | 60 | |||||
Issuance of Common Stock for services, shares | 24,964 | ||||||
Stock-Based Compensation | 48 | 48 | |||||
Balance at Mar. 31, 2019 | $ 12 | 107,656 | (88) | (202) | (1,525) | (80,302) | 25,551 |
Balance, shares at Mar. 31, 2019 | 11,969,179 | ||||||
Balance at Dec. 31, 2018 | $ 12 | 107,548 | (88) | (214) | (1,495) | (79,630) | 26,133 |
Balance, shares at Dec. 31, 2018 | 11,944,215 | ||||||
Net Income (loss) | 1,295 | ||||||
Foreign currency translation | 12 | ||||||
Balance at Sep. 30, 2019 | $ 12 | 108,215 | (88) | (202) | (1,585) | (78,245) | 28,107 |
Balance, shares at Sep. 30, 2019 | 12,077,418 | ||||||
Balance at Mar. 31, 2019 | $ 12 | 107,656 | (88) | (202) | (1,525) | (80,302) | 25,551 |
Balance, shares at Mar. 31, 2019 | 11,969,179 | ||||||
Net Income (loss) | (31) | 289 | 258 | ||||
Foreign currency translation | (4) | (4) | |||||
Issuance of Common Stock for services | 62 | 62 | |||||
Issuance of Common Stock for services, shares | 17,902 | ||||||
Stock-Based Compensation | 36 | 36 | |||||
Issuance of Common Stock with debt | 263 | 263 | |||||
Issuance of Common Stock with debt, shares | 75,000 | ||||||
Issuance of warrant with debt | 93 | 93 | |||||
Balance at Jun. 30, 2019 | $ 12 | 108,110 | (88) | (206) | (1,556) | (80,013) | 26,259 |
Balance, shares at Jun. 30, 2019 | 12,062,081 | ||||||
Net Income (loss) | (29) | 1,768 | 1,739 | ||||
Foreign currency translation | 4 | 4 | |||||
Issuance of Common Stock for services | 60 | 60 | |||||
Issuance of Common Stock for services, shares | 15,337 | ||||||
Stock-Based Compensation | 45 | 45 | |||||
Balance at Sep. 30, 2019 | $ 12 | 108,215 | (88) | (202) | (1,585) | (78,245) | 28,107 |
Balance, shares at Sep. 30, 2019 | 12,077,418 | ||||||
Balance at Dec. 31, 2019 | $ 12 | 108,457 | (88) | (211) | (1,619) | (77,315) | 29,236 |
Balance, shares at Dec. 31, 2019 | 12,123,520 | ||||||
Net Income (loss) | (26) | 1,220 | 1,194 | ||||
Foreign currency translation | (79) | (79) | |||||
Issuance of Common Stock for services | 48 | 48 | |||||
Issuance of Common Stock for services, shares | 5,128 | ||||||
Issuance of Common Stock upon exercise of options | 6 | 6 | |||||
Issuance of Common Stock upon exercise of options, shares | 3,643 | ||||||
Stock-Based Compensation | 44 | 44 | |||||
Balance at Mar. 31, 2020 | $ 12 | 108,555 | (88) | (290) | (1,645) | (76,095) | 30,449 |
Balance, shares at Mar. 31, 2020 | 12,132,291 | ||||||
Balance at Dec. 31, 2019 | $ 12 | 108,457 | (88) | (211) | (1,619) | (77,315) | 29,236 |
Balance, shares at Dec. 31, 2019 | 12,123,520 | ||||||
Net Income (loss) | 2,783 | ||||||
Foreign currency translation | (40) | ||||||
Balance at Sep. 30, 2020 | $ 12 | 108,790 | (88) | (251) | (1,706) | (74,445) | 32,312 |
Balance, shares at Sep. 30, 2020 | 12,152,363 | ||||||
Balance at Mar. 31, 2020 | $ 12 | 108,555 | (88) | (290) | (1,645) | (76,095) | 30,449 |
Balance, shares at Mar. 31, 2020 | 12,132,291 | ||||||
Net Income (loss) | (29) | 204 | 175 | ||||
Foreign currency translation | 28 | 28 | |||||
Issuance of Common Stock for services | 56 | 56 | |||||
Issuance of Common Stock for services, shares | 10,239 | ||||||
Issuance of Common Stock upon exercise of options | |||||||
Issuance of Common Stock upon exercise of options, shares | 241 | ||||||
Stock-Based Compensation | 48 | 48 | |||||
Balance at Jun. 30, 2020 | $ 12 | 108,659 | (88) | (262) | (1,674) | (75,891) | 30,756 |
Balance, shares at Jun. 30, 2020 | 12,142,771 | ||||||
Net Income (loss) | (32) | 1,446 | 1,414 | ||||
Foreign currency translation | 11 | 11 | |||||
Issuance of Common Stock for services | 62 | 62 | |||||
Issuance of Common Stock for services, shares | 9,592 | ||||||
Stock-Based Compensation | 69 | 69 | |||||
Balance at Sep. 30, 2020 | $ 12 | $ 108,790 | $ (88) | $ (251) | $ (1,706) | $ (74,445) | $ 32,312 |
Balance, shares at Sep. 30, 2020 | 12,152,363 |
Consolidated Statements of Cash
Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands | 9 Months Ended | |||
Sep. 30, 2020 | Sep. 30, 2019 | |||
Cash flows from operating activities: | ||||
Net income | $ 2,783 | $ 1,295 | ||
Less: loss from discontinued operations, net of taxes of $0 | (266) | (424) | ||
Income from continuing operations, net of taxes | 3,049 | 1,719 | ||
Adjustments to reconcile income from continuing operations to cash provided by (used in) operating activities: | ||||
Depreciation and amortization | 1,189 | 968 | ||
Interest on finance lease with purchase option | 6 | |||
Loss on extinguishment of debt | 27 | |||
Amortization of debt issuance/debt discount costs | 187 | 139 | ||
Deferred tax (benefit) expense | (2) | 26 | ||
(Recovery of) provision for bad debt reserves | (94) | 147 | ||
Loss on disposal of property and equipment | 27 | 3 | ||
Issuance of common stock for services | 166 | 182 | ||
Stock-based compensation | 161 | 129 | ||
Changes in operating assets and liabilities of continuing operations | ||||
Accounts receivable | (170) | (3,193) | ||
Unbilled receivables | (6,382) | (6,140) | ||
Prepaid expenses, inventories and other assets | 1,284 | 500 | ||
Accounts payable, accrued expenses and unearned revenue | 4,055 | 2,516 | ||
Cash provided by (used in) continuing operations | 3,503 | (3,004) | ||
Cash used in discontinued operations | (329) | (459) | ||
Cash provided by (used in) operating activities | 3,174 | (3,463) | ||
Cash flows from investing activities: | ||||
Purchases of property and equipment | (1,488) | [1] | (813) | [2] |
Proceeds from sale of property and equipment | 4 | 1 | ||
Cash used in investing activities of continuing operations | (1,484) | (812) | ||
Cash provided by investing activities of discontinued operations | 118 | 100 | ||
Cash used in investing activities | (1,366) | (712) | ||
Cash flows from financing activities: | ||||
Repayments of revolving credit borrowings | (72,601) | (38,378) | ||
Borrowing on revolving credit | 72,280 | 37,739 | ||
Proceeds from issuance of long-term debt | 5,666 | 2,500 | ||
Proceeds from finance leases | 405 | |||
Principal repayments of finance lease liabilities | (411) | (174) | ||
Principal repayments of long term debt | (2,127) | (925) | ||
Payment of debt issuance costs | (85) | (112) | ||
Proceeds from issuance of common stock upon exercise of options | 6 | |||
Cash provided by financing activities of continuing operations | 2,728 | 1,055 | ||
Effect of exchange rate changes on cash | (4) | 16 | ||
Increase (decrease) in cash and finite risk sinking fund (restricted cash) | 4,532 | (3,104) | ||
Cash and finite risk sinking fund (restricted cash) at beginning of period | 11,697 | 16,781 | ||
Cash and finite risk sinking fund (restricted cash) at end of period | 16,229 | 13,677 | ||
Supplemental disclosure: | ||||
Interest paid | 286 | 284 | ||
Income taxes paid | 34 | 168 | ||
Equipment purchase subject to finance lease | 856 | 29 | ||
Equipment purchase subject to financing | 27 | |||
Issuance of Common Stock with debt | 263 | |||
Issuance of Warrant with debt | $ 93 | |||
[1] | Net of financed amount of $751,000 and $883,000 for the three and nine months ended September 30, 2020, respectively. | |||
[2] | Net of financed amount of $6,000 and $29,000 for the three and nine months ended September 30, 2019, respectively. |
Consolidated Statements of Ca_2
Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Statement of Cash Flows [Abstract] | ||||
Loss from discontinued operations, tax | $ 0 | $ 0 | $ 0 | $ 0 |
Basis of Presentation
Basis of Presentation | 9 Months Ended |
Sep. 30, 2020 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | 1. Basis of Presentation The consolidated financial statements included herein have been prepared by the Company (which may be referred to as we, us or our), without an audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“the Commission”). Certain information and note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations, although the Company believes the disclosures which are made are adequate to make the information presented not misleading. Further, the consolidated financial statements reflect, in the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position and results of operations as of and for the periods indicated. The results of operations for the nine months ended September 30, 2020 are not necessarily indicative of results to be expected for the fiscal year ending December 31, 2020. The Company suggests that these consolidated financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. The consolidated financial statements include our accounts, those of our wholly-owned subsidiaries, and our majority-owned Polish subsidiary, Perma-Fix Medical. Additionally, the Company’s financial statements include the account of a variable interest entity (“VIE”), Perma-Fix ERRG for which we are the primary beneficiary (See “Note 14 - VIE” for a discussion of this VIE). |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 9 Months Ended |
Sep. 30, 2020 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | 2. Summary of Significant Accounting Policies Recently Adopted Accounting Standards In August 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.” ASU 2018-13 improves the disclosure requirements on fair value measurements. ASU 2018-13 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The adoption of ASU No. 2018-13 by the Company effective January 1, 2020 did not have a material impact on the Company’s financial statements or disclosures. In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (“ASU 848”): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” ASU 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference London Interbank Offered Rate (“LIBOR”) or another rate that is expected to be discontinued. The amendments in the ASU are effective for all entities as of March 12, 2020 through December 31, 2022. The adoption of ASU 2020-04 on March 12, 2020 by the Company did not have a material impact on the Company’s financial statements. The Company will continue to assess the potential impact of this ASU through the effective period. Recently Issued Accounting Standards – Not Yet Adopted In June 2016, the FASB issued ASU No. 2016-13, “Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments and subsequent amendments to the initial guidance: ASU 2018-19 “Codification Improvements to Topic 326, Financial Instruments - Credit Losses,” ASU 2019-04 “Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments,” ASU 2019-05 “Financial Instruments - Credit Losses (Topic 326): Targeted Transition Relief,” ASU 2019-11 “Codification Improvements to Topic 326, Financial Instruments - Credit Losses” and ASU 2020-02, “Financial Instruments—Credit Losses (Topic 326) and Leases (Topic 842)” (collectively, “Topic 326”). Topic 326 introduces an approach, based on expected losses, to estimate credit losses on certain types of financial instruments and modifies the impairment model for available-for-sale debt securities. The new approach to estimating credit losses (referred to as the current expected credit losses model) applies to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables and loans. Entities are required to apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. These ASUs are effective January 1, 2023 for the Company as a smaller reporting company. The Company had expected to early adopt theses ASUs effective January 1, 2020; however, due to the need for reallocation of the Company’s resources to manage COVID-19 related matters, the Company has deferred adoption of theses ASUs effective January 1, 2020 and expect to adopt these ASUs by January 1, 2023. In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes,” which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company does not expect the adoption of this ASU will have a material impact on the Company’s financial statements. In January 2020, the FASB issued ASU 2020-01, “Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815), clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” This guidance addresses accounting for the transition into and out of the equity method and provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2020. Early adoption is permitted. The Company does not expect the adoption of this ASU will have a material impact on the Company’s financial statements. In August 2020, the FASB issued ASU No. 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity.” ASU 2020-06 simplifies the accounting for convertible instruments by removing major separation models and removing certain settlement condition qualifiers for the derivatives scope exception for contracts in an entity’s own equity, and simplifies the related diluted net income per share calculation for both Subtopics. ASU 2020-06 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023, for the Company as a smaller reporting company. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is currently evaluating the impact of this ASU on its consolidated financial statements and disclosures. |
COVID-19 Impact
COVID-19 Impact | 9 Months Ended |
Sep. 30, 2020 | |
pesi_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndOtherLiabilities | |
COVID-19 Impact | 3. COVID-19 Impact The spread of COVID-19 continues to result in significant volatility in the U.S. and international markets. The Company continues to closely monitor the impact of the COVID-19 pandemic on all aspects of its business. As previously reported, the COVID-19 pandemic did not result in a material impact to the Company’s first quarter 2020 results of operations. Starting in late March 2020, the Company’s operations were impacted by the shutdown of a number of projects and the delays of certain waste shipments that continued into the second quarter of 2020. Since the latter part of the second quarter of 2020, all of the projects that were previously shutdown within our Services Segment have restarted as stay-at-home orders and certain other restrictions resulting from the pandemic were lifted. Revenues within our Services Segment in the third quarter of 2020 exceeded the corresponding period of 2019 by approximately $10,652,000. The Company continues to experience delays in waste shipments from certain customers within our Treatment Segment directly related to the impact of COVID-19 including generator shutdowns and limited sustained operations, along with other factors. These waste shipment delays may impact the Company’s results of operations for the fourth quarter of 2020 and potentially the first quarter of 2021. At this time, the Company believes it has sufficient liquidity on hand to continue business operations during the next twelve months. At September 30, 2020, the Company had cash on hand of approximately $4,811,000 and borrowing availability under our revolving credit facility of approximately $16,404,000 based on a percentage of eligible receivables and subject to certain reserves. The Company continues to assess reducing operating costs during this volatile time, which include curtailing capital expenditures, eliminating non-essential expenditures and implementing a hiring freeze as needed. The Company is closely monitoring our customers’ payment performance. However, as a significant portion of our revenues is derived from government related contracts, the Company does not expect its accounts receivable collections to be materially impacted due to COVID-19. The situation surrounding COVID-19 continues to remain fluid. The potential for a material impact on the Company’s business increases the longer COVID-19 impacts the level of economic activities in the United States and globally as our customers may continue to delay waste shipments and project work may shut down again. For this reason, we cannot reasonably estimate with any degree of certainty the future impact COVID-19 may have on our results of operations, financial position, and liquidity which may impact our ability to meet our financial covenant requirements under our credit facility. Given the current economic environment and the market volatility from COVID-19, the Company considered whether these events or changes in circumstances triggered the need for an interim impairment analysis of our long-lived assets and intangible assets. Based on the Company’s assessment of the impact of these conditions on our business, the Company determined there was no triggering event as of September 30, 2020. However, as the effects of the COVID-19 pandemic continue to evolve, the Company will continue to assess the need to perform interim impairment tests of our long-lived assets and intangible assets. The Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), as amended by the Paycheck Protection Program Flexibility Act of 2020 (the “Flexibility Act”) on June 5, 2020, provides the Company the option to defer the payment of its share of social security taxes beginning on March 27, 2020 through December 31, 2020. The Company elected to defer payment of its shares of social security taxes starting in April 2020 (see “Note 15 – Deferral of Employment Tax Deposits”). The Company also entered into a promissory note (“PPP Loan”) with its credit facility lender under the Paycheck Protection Program (“PPP”) that was established under the CARES Act, as amended (see “Note 9 – Long Term Debt – PPP Loan” for further detail of this loan). |
Revenue
Revenue | 9 Months Ended |
Sep. 30, 2020 | |
Revenue from Contract with Customer [Abstract] | |
Revenue | 4. Revenue Disaggregation of Revenue In general, the Company’s business segmentation is aligned according to the nature and economic characteristics of our services and provides meaningful disaggregation of each business segment’s results of operations. The nature of the Company’s performance obligations within our Treatment and Services Segments result in the recognition of our revenue primarily over time. The following tables present further disaggregation of our revenues by different categories for our Services and Treatment Segments: Revenue by Contract Type (In thousands) Three Months Ended Three Months Ended September 30, 2020 September 30, 2019 Treatment Services Total Treatment Services Total Fixed price $ 7,066 $ 10,303 $ 17,369 $ 10,081 $ 5,364 $ 15,445 Time and materials — 12,803 12,803 — 7,090 7,090 Total $ 7,066 $ 23,106 $ 30,172 $ 10,081 $ 12,454 $ 22,535 Revenue by Contract Type Nine Months Ended Nine Months Ended (In thousands) September 30, 2020 September 30, 2019 Treatment Services Total Treatment Services Total Fixed price $ 24,469 $ 19,001 $ 43,470 $ 30,079 $ 9,231 $ 39,310 Time and materials — 33,609 33,609 — 12,068 12,068 Total $ 24,469 $ 52,610 $ 77,079 $ 30,079 $ 21,299 $ 51,378 Revenue by generator Three Months Ended Three Months Ended (In thousands) September 30, 2020 September 30, 2019 Treatment Services Total Treatment Services Total Domestic government $ 5,334 $ 21,660 $ 26,994 $ 7,537 $ 10,155 $ 17,692 Domestic commercial 1,598 459 2,057 2,535 475 3,010 Foreign government 134 966 1,100 — 1,804 1,804 Foreign commercial — 21 21 9 20 29 Total $ 7,066 $ 23,106 $ 30,172 $ 10,081 $ 12,454 $ 22,535 Revenue by generator Nine Months Ended Nine Months Ended (In thousands) September 30, 2020 September 30, 2019 Treatment Services Total Treatment Services Total Domestic government $ 19,079 $ 48,249 $ 67,328 $ 21,986 $ 15,683 $ 37,669 Domestic commercial 5,256 1,352 6,608 7,809 2,088 9,897 Foreign government 134 2,945 3,079 220 3,465 3,685 Foreign commercial — 64 64 64 63 127 Total $ 24,469 $ 52,610 $ 77,079 $ 30,079 $ 21,299 $ 51,378 Contract Balances The timing of revenue recognition, billings, and cash collections results in accounts receivable and unbilled receivables (contract assets). The Company’s contract liabilities consist of deferred revenues which represents advance payment from customers in advance of the completion of our performance obligation. The following table represents changes in our contract assets and contract liabilities balances: (In thousands) September 30, 2020 December 31, 2019 Year-to-date Change ($) Year-to-date Change (%) Contract assets Account receivables, net of allowance $ 13,442 $ 13,178 $ 264 2.0 % Unbilled receivables - current 14,366 7,984 6,382 79.9 % Contract liabilities Deferred revenue $ 4,806 $ 5,456 $ (650 ) (11.9 )% During the three and nine months ended September 30, 2020, the Company recognized revenue of $1,134,000 and $7,673,000, respectively, related to untreated waste that was in the Company’s control as of the beginning of the year. During the three and nine months ended September 30, 2019, the Company recognized revenue of $1,877,000 and $9,322,000, respectively, related to untreated waste that was in the Company’s control as of the beginning of the year. All revenue recognized in each period related to performance obligations satisfied within the respective period. Remaining Performance Obligations The Company applies the practical expedient in FASB Accounting Standards Codification (“ASC”) 606-10-50-14 and does not disclose information about remaining performance obligations that have original expected durations of one year or less. Within our Services Segment, there are service contracts which provide that the Company has a right to consideration from a customer in an amount that corresponds directly with the value to the customer of our performance completed to date. For those contracts, the Company has utilized the practical expedient in ASC 606-10-55-18, which allows the Company to recognize revenue in the amount for which we have the right to invoice; accordingly, the Company does not disclose the value of remaining performance obligations for those contracts. |
Leases
Leases | 9 Months Ended |
Sep. 30, 2020 | |
Leases [Abstract] | |
Leases | 5. Leases The Company’s operating lease right-of-use (“ROU”) assets and operating lease liabilities represent primarily leases for office spaces used to conduct our business. These leases have remaining terms of approximately 3 to 10 years which include one or more options to renew (which are included in valuing our ROU assets and liabilities). As most of our operating leases do not provide an implicit rate, the Company uses its incremental borrowing rate as the discount rate when determining the present value of the lease payments. The incremental borrowing rate is determined based on the Company’s secured borrowing rate, lease terms and current economic environment. Lease expense for operating leases is recognized on a straight-line basis over the lease term. Finance leases primarily consist of processing and transport equipment used by our facilities’ operations. Our finance leases also include a building with land for our waste treatment operations. The Company’s finance leases generally have initial terms between one to six years and some of the leases include options to purchase the underlying assets at fair market value at the conclusion of the lease term. The lease for the building and land has a term of two years with an option to buy at the end of the lease term, which the Company is reasonably certain to exercise. The Company adopted the policy to not recognize ROU assets and liabilities for short term leases. The components of lease cost for the Company’s leases for the three and nine months ended September 30, 2020 and 2019 were as follows (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Operating Leases: Lease cost $ 114 $ 114 $ 342 $ 342 Finance Leases: Amortization of ROU assets 109 20 161 39 Interest on lease liability 47 15 97 40 156 35 258 79 Short-term lease rent expense 3 41 7 113 Total lease cost $ 273 $ 190 $ 607 $ 534 The weighted average remaining lease term and the weighted average discount rate for operating and finance leases at September 30, 2020 were: Operating Leases Finance Leases Weighted average remaining lease terms (years) 8.2 3.4 Weighted average discount rate 8.0 % 7.9 % The following table reconciles the undiscounted cash flows for the operating and finance leases at September 30, 2020 to the operating and finance lease liabilities recorded on the balance sheet (in thousands): Operating Leases Finance Leases 2020 Remainder $ 112 $ 263 2021 450 554 2022 458 272 2023 466 149 2024 342 146 2025 and thereafter 1,457 164 Total undiscounted lease payments 3,285 1,548 Less: Imputed interest (879 ) (158 ) Present value of lease payments $ 2,406 $ 1,390 Current portion of operating lease obligations $ 265 $ — Long-term operating lease obligations, less current portion $ 2,141 $ — Current portion of finance lease obligations $ — $ 675 Long-term finance lease obligations, less current portion $ — $ 715 Supplemental cash flow and other information related to our leases were as follows for the three and nine months ended September 30, 2020 and 2019 (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flow used in operating leases $ 111 $ 109 $ 331 $ 326 Operating cash flow used in finance leases $ 47 $ 15 $ 97 $ 40 Financing cash flow used in finance leases $ 182 $ 73 $ 411 $ 174 ROU assets obtained in exchange for lease obligations for: Finance liabilities $ 751 $ 390 $ 874 $ 528 Operating liabilities $ — — — 182 |
Intangible Assets
Intangible Assets | 9 Months Ended |
Sep. 30, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Intangible Assets | 6. Intangible Assets The following table summarizes information relating to the Company’s definite-lived intangible assets: Weighted Average September 30, 2020 December 31, 2019 Amortization Gross Net Gross Net Period Carrying Accumulated Carrying Carrying Accumulated Carrying Intangibles (amount in thousands) (Years) Amount Amortization Amount Amount Amortization Amount Patent 9.7 $ 785 $ (375 ) $ 410 $ 760 $ (358 ) $ 402 Software 3 414 (410 ) 4 414 (408 ) 6 Customer relationships 10 3,370 (2,861 ) 509 3,370 (2,713 ) 657 Total $ 4,569 $ (3,646 ) $ 923 $ 4,544 $ (3,479 ) $ 1,065 The intangible assets noted above are amortized on a straight-line basis over their useful lives with the exception of customer relationships which are being amortized using an accelerated method. The following table summarizes the expected amortization over the next five years for our definite-lived intangible assets: Amount Year (In thousands) 2020 (remaining) $ 56 2021 202 2022 176 2023 135 2024 13 Amortization expense relating to the definite-lived intangible assets as discussed above was $58,000 and $167,000 for the three and nine months ended September 30, 2020, respectively, and $60,000 and $194,000 for the three and nine months ended September 30, 2019, respectively. |
Capital Stock, Stock Plans and
Capital Stock, Stock Plans and Stock-Based Compensation | 9 Months Ended |
Sep. 30, 2020 | |
Share-based Payment Arrangement [Abstract] | |
Capital Stock, Stock Plans and Stock Based Compensation | 7. Capital Stock, Stock Plans and Stock-Based Compensation The Company has certain stock option plans under which it may awards incentive stock options (“ISOs”) and/or non-qualified stock options (“NQSOs”) to employees, officers, outside directors, and outside consultants. On August 10, 2020, the Company granted 6,000 NQSOs from the Company’s 2003 Outside Directors Stock Plan (“2003 Plan”) to a new director elected by the Company’s Board of Directors (“Board”) to fill a vacancy on the Board. The options granted were for a contractual term of ten years with a vesting period of six months. The exercise price of the options was $7.29 per share, which was equal to the Company’s closing stock price per share the day preceding the grant date, pursuant to the 2003 Plan. On July 22, 2020, the Company granted an aggregate of 12,000 NQSOs from the Company’s 2003 Plan to five of the six re-elected directors at the Company’s Annual Meeting of Stockholders held on July 22, 2020. Dr. Louis F. Centofanti, the Company’s Executive Vice President (“EVP”) of Strategic Initiatives and also a Board member, was not eligible to receive options under the 2003 Plan as an employee of the Company, pursuant to the 2003 Plan. The NQSOs granted were for a contractual term of ten years with a vesting period of six months. The exercise price of the NQSO was $6.70 per share, which was equal to our closing stock price the day preceding the grant date, pursuant to the 2003 Plan. On February 4, 2020, the Company granted 6,000 NQSOs from the Company’s 2003 Plan to a new director elected by the Company’s Board to fill a vacancy on the Board. The options granted were for a contractual term of ten years with a vesting period of six months. The exercise price of the options was $7.00 per share, which was equal to the Company’s closing stock price per share the day preceding the grant date, pursuant to the 2003 Plan. On August 29, 2019 the Company granted an aggregate of 12,500 ISOs from the 2017 Stock Option Plan (“2017 Plan”) to certain employees. The ISOs granted were for a contractual term of six years with one-fifth vesting annually over a five year period. The exercise price of the ISO was $3.90 per share, which was equal to the fair market value of the Company’s Common Stock on the date of grant. On July 25, 2019, the Company granted an aggregate of 12,000 NQSOs from the Company’s 2003 Plan to five of the six re-elected directors at the Company’s Annual Meeting of Stockholders held on July 25, 2019. Dr. Louis F. Centofanti (a Board member) was not eligible to receive options under the 2003 Plan as an employee of the Company, pursuant to the 2003 Plan. The NQSOs granted were for a contractual term of ten years with a vesting period of six months. The exercise price of the NQSO was $3.31 per share, which was equal to our closing stock price the day preceding the grant date, pursuant to the 2003 Plan. On January 17, 2019 the Company granted 105,000 ISOs from the 2017 Plan to certain employees, which included an aggregate of 55,000 ISOs to certain of our executive officers. The ISOs granted were for a contractual term of six years with one-fifth vesting annually over a five year period. The exercise price of the ISO was $3.15 per share, which was equal to the fair market value of the Company’s Common Stock on the date of grant. The Company granted a NQSO to Robert Ferguson on July 27, 2017 from the Company’s 2017 Plan for the purchase of up to 100,000 shares of the Company’s Common Stock (“Ferguson Stock Option”) in connection with his work as a consultant to the Company’s Test Bed Initiative (“TBI”) at our Perma-Fix Northwest Richland, Inc. (“PFNWR”) facility at an exercise price of $3.65 per share, which was the fair market value of the Company’s Common Stock on the date of grant. The term of the Ferguson Stock Option is seven years from the grant date. The vesting of the Ferguson Stock Option is subject to the achievement of three separate milestones by certain dates. On January 17, 2019, the Company’s Compensation and Stock Option Committee (“Compensation Committee”) and Board approved an amendment to the Ferguson Stock Option whereby the vesting date for the second milestone for the purchase of up to 30,000 shares of the Company’s Common Stock was extended to March 31, 2020 from January 27, 2019. On March 27, 2020, the Compensation Committee and the Board approved another amendment to the Ferguson Stock Option whereby the vesting date for the second milestone was further extended to December 31, 2021 from March 31, 2020 and the vesting date for the third milestone for the purchase of up to 60,000 shares of the Company’s Common Stock was extended to December 31, 2022 from January 27, 2021. The 10,000 options under the first milestone were exercised by Robert Ferguson in May 2018. The Company has not recognized compensation costs (fair value of approximately $262,000 at September 30, 2020) for the remaining 90,000 Ferguson Stock Option under the remaining two milestones since achievement of the performance obligation under each of the two remaining milestones is uncertain at September 30, 2020. All other terms of the Ferguson Stock Option remain unchanged. The Company estimates fair value of stock options using the Black-Scholes valuation model. Assumptions used to estimate the fair value of stock options granted include the exercise price of the award, the expected term, the expected volatility of the Company’s stock over the option’s expected term, the risk-free interest rate over the option’s expected term, and the expected annual dividend yield. The fair value of the options granted as discussed above and the related assumptions used in the Black-Scholes option model used to value the options granted for the nine months ended September 30, 2020 and 2019 were as follows: Employee Stock Option Granted Nine Months Ended September 30, 2019 Weighted-average fair value per share $ 1.46 Risk -free interest rate (1) 1.4%-2.58 % Expected volatility of stock (2) 48.67%-51.38 % Dividend yield None Expected option life (3) 5.0 years Outside Director Stock Option Granted Nine Months Ended September 30, 2020 2019 Weighted-average fair value per share $ 4.66 $ 2.27 Risk -free interest rate (1) 0.59%-1.61 % 2.08 % Expected volatility of stock (2) 55.83%-56.68 % 54.28 % Dividend yield None None Expected option life (3) 10.0 years 10.0 years (1) The risk-free interest rate is based on the U.S. Treasury yield in effect at the grant date over the expected term of the option. (2) The expected volatility is based on historical volatility from our traded Common Stock over the expected term of the option. (3) The expected option life is based on historical exercises and post-vesting data. The following table summarizes stock-based compensation recognized for the three and nine months ended September 30, 2020 and 2019 for our employee and director stock options. Three Months Ended Nine Months Ended Stock Options September 30, September 30, 2020 2019 2020 2019 Employee Stock Options $ 34,000 $ 35,000 $ 99,000 $ 114,000 Director Stock Options 35,000 10,000 62,000 15,000 Total $ 69,000 $ 45,000 $ 161,000 $ 129,000 At September 30, 2020, the Company has approximately $349,000 of total unrecognized compensation costs related to unvested options for employee and directors. The weighted average period over which the unrecognized compensation costs are expected to be recognized is approximately 2.1 years. The summary of the Company’s total Stock Option Plans as of September 30, 2020 and September 30, 2019, and changes during the periods then ended, are presented below. The Company’s Plans consist of the 2010 Stock Option Plan, the 2017 Plans and the 2003 Plan: Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (years) Aggregate Intrinsic Value (4) Options outstanding January 1, 2020 681,300 $ 3.84 Granted 24,000 $ 6.92 Exercised (12,500 ) $ 3.47 $ 16,060 Forfeited/expired (34,400 ) $ 5.52 Options outstanding end of period (1) 658,400 $ 3.87 3.7 $ 2,096,355 Options exercisable at September 30, 2020 (2) 340,400 $ 4.01 3.6 $ 1,036,255 Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (years) Aggregate Intrinsic Value (4) Options outstanding January 1, 2019 616,000 $ 4.23 Granted 129,500 $ 3.24 Exercised ─ $ ─ Forfeited/expired (31,800 ) $ 8.68 Options outstanding end of period (3) 713,700 $ 3.85 4.4 $ 611,942 Options exercisable as of September 30, 2019 (3) 299,200 $ 4.30 4.0 $ 188,082 (1) (2) (3) (4) During the nine months ended September 30, 2020, the Company issued a total of 24,959 shares of its Common Stock under the 2003 Plan to its outside directors as compensation for serving on our Board. The Company has recorded approximately $179,000 in compensation expenses (included in selling, general and administration (“SG&A”) expenses) in connection with the issuance of shares of its Common Stock to outside directors. During the nine months ended September 30, 2020, the Company issued 2,000 shares of its Common Stock resulting from the exercise of options from the Company’s 2017 Plan for total proceeds of $6,300. Additionally, the Company issued 1,884 shares of its Common Stock from cashless exercises of 8,000 and 2,500 options at $3.60 per share and $3.15 per share, respectively. |
Income Per Share
Income Per Share | 9 Months Ended |
Sep. 30, 2020 | |
Earnings Per Share [Abstract] | |
Income Per Share | 8. Income Per Share Basic income per share is calculated based on the weighted-average number of outstanding common shares during the applicable period. Diluted income per share is based on the weighted-average number of outstanding common shares plus the weighted-average number of potential outstanding common shares. In periods where they are anti-dilutive, such amounts are excluded from the calculations of dilutive earnings per share. The following table reconciles the income (loss) and average share amounts used to compute both basic and diluted income per share: Three Months Ended Nine Months Ended September 30, September 30, (Amounts in Thousands, (Unaudited) (Unaudited) Except for Per Share Amounts) 2020 2019 2020 2019 Net income attributable to Perma-Fix Environmental Services, Inc., common stockholders: Income from continuing operations, net of taxes $ 1,481 1,895 3,049 1,719 Net loss attributable to non-controlling interest (32 ) (29 ) (87 ) (90 ) Income from continuing operations attributable to Perma-Fix Environmental Services, Inc. common stockholders $ 1,513 $ 1,924 $ 3,136 $ 1,809 Loss from discontinuing operations attributable to Perma-Fix Environmental Services, Inc. common stockholders (67 ) (156 ) (266 ) (424 ) Net income attributable to Perma-Fix Environmental Services, Inc. common stockholders $ 1,446 $ 1,768 $ 2,870 $ 1,385 Basic income per share attributable to Perma-Fix Environmental Services, Inc. common stockholders $ .12 $ .15 $ .24 $ .12 Diluted income per share attributable to Perma-Fix Environmental Services, Inc. common stockholders $ .12 $ .15 $ .23 $ .11 Weighted average shares outstanding: Basic weighted average shares outstanding 12,145 12,070 12,134 12,029 Add: dilutive effect of stock options 201 47 181 29 Add: dilutive effect of warrant 25 6 22 3 Diluted weighted average shares outstanding 12,371 12,123 12,337 12,061 Potential shares excluded from above weighted average share calculations due to their anti-dilutive effect include: Stock options 30 159 42 165 Warrant — — — — |
Long Term Debt
Long Term Debt | 9 Months Ended |
Sep. 30, 2020 | |
Debt Disclosure [Abstract] | |
Long Term Debt | 9. Long Term Debt Long-term debt consists of the following at September 30, 2020 and December 31, 2019: (Amounts in Thousands) September 30, 2020 December 31, 2019 Revolving Credit (1) $ — $ 321 Term Loan (1) 1,487 (2) 1,827 (2) Promissory Note (3) 424 (4) 1,732 (4) Promissory Note (3) 5,318 (5) — Note Payable 25 — Total debt 7,254 3,880 Less current portion of long-term debt 828 (4) 1,300 (4) Long-term debt $ 6,426 $ 2,580 (1) (2) (3) (4) (5) Revolving Credit and Term Loan Agreement The Company entered into an Amended and Restated Revolving Credit, Term Loan and Security Agreement, dated October 31, 2011 (“Amended Loan Agreement”), with PNC National Association (“PNC”), acting as agent and lender. The Amended Loan Agreement had been amended from time to time since the execution of the Amended Loan Agreement. The Amended Loan Agreement, as subsequently amended (“Revised Loan Agreement”), provided the Company with the following credit facility with a maturity date of March 24, 2021: (a) up to $12,000,000 revolving credit (“revolving credit”) and (b) a term loan (“term loan”) of approximately $6,100,000. The maximum that the Company can borrow under the revolving credit was based on a percentage of eligible receivables (as defined) at any one time reduced by outstanding standby letters of credit and borrowing reductions that our lender may impose from time to time. Payment of annual rate of interest due on the revolving credit under the Revised Loan Agreement was at prime (3.25% at September 30, 2020) plus 2% and the term loan at prime plus 2.5%. On May 8, 2020, the Company entered into a Second Amended and Restated Revolving Credit, Term Loan and Security Agreement (the “New Loan Agreement”) with PNC, replacing our previous Revised Loan Agreement with PNC. The New Loan Agreement provides the Company with the following credit facility: ● up to $18,000,000 revolving credit facility, subject to the amount of borrowings based on a percentage of eligible receivables and subject to certain reserves; and ● a term loan of $1,741,818, which requires monthly installments of $35,547. The New Loan Agreement terminates as of May 15, 2024, unless sooner terminated. Similar to our Revised Loan Agreement, the New Loan Agreement requires the Company to meet certain customary financial covenants, including, among other things, a minimum Tangible Adjusted Net Worth requirement of $27,000,000 at all times; maximum capital spending of $6,000,000 annually; and a minimum fixed charge coverage ratio (“FCCR”) requirement of 1.15:1. Under the New Loan Agreement, payment of annual rate of interest due on the credit facility is as follows: ● revolving credit at prime plus 2.50% or LIBOR plus 3.50% and the term loan at prime plus 3.00% or LIBOR plus 4.00%. The Company can only elect to use the LIBOR interest payment option after it becomes compliant with meeting the minimum FCCR of 1.15:1; and ● Upon the achievement of a FCCR of greater than 1.25:1, the Company has the option of paying an annual rate of interest due on the revolving credit at prime plus 2.00% or LIBOR plus 3.00% and the term loan at prime plus 2.50% or LIBOR plus 3.50%. The Company met this FCCR in the first, second and third quarters of 2020. Upon meeting the FCCR of 1.25:1, this interest payment option will remain in place in the event that the Company’s future FCCR falls below 1.25:1. Under the LIBOR option of interest payment noted above, a LIBOR floor of 0.75% shall apply in the event that LIBOR falls below 0.75% at any point in time. Pursuant to the New Loan Agreement, the Company may terminate the New Loan Agreement upon 90 days’ prior written notice upon payment in full of our obligations under the New Loan Agreement. The Company has agreed to pay PNC 1.0% of the total financing in the event we pay off our obligations on or before May 7, 2021 and 0.5% of the total financing if we pay off our obligations after May 7, 2021 but prior to or on May 7, 2022. No early termination fee shall apply if we pay off our obligations under the New Loan Agreement after May 7, 2022. In connection with New Loan Agreement, the Company paid its lender a fee of $50,000 and incurred other direct costs of approximately $35,000, which are being amortized over the term of the New Loan Agreement as interest expense-financing fees. As a result of the termination of the Revised Loan Agreement, the Company recorded approximately $27,000 in loss on extinguishment of debt in accordance with ASC 470-50, “Debt – Modifications and Extinguishment.” At September 30, 2020, the borrowing availability under our revolving credit was approximately $16,404,000, based on our eligible receivables and includes a reduction in borrowing availability of approximately $3,026,000 from outstanding standby letters of credit. The Company’s credit facility under its Revised and New Loan Agreement with PNC contains certain financial covenants, along with customary representations and warranties. A breach of any of these financial covenants, unless waived by PNC, could result in a default under our credit facility allowing our lender to immediately require the repayment of all outstanding debt under our credit facility and terminate all commitments to extend further credit. The Company met its FCCR requirement in the first, second and third quarters of 2020. Additionally, the Company met its remaining financial covenant requirements in the first, second and third quarters of 2020. Loan and Securities Purchase Agreement, Promissory Note and Subordination Agreement On April 1, 2019, the Company completed a lending transaction with Robert Ferguson (the “Lender”), whereby the Company borrowed from the Lender the sum of $2,500,000 pursuant to the terms of a Loan and Security Purchase Agreement and promissory note (the “Loan”). The Lender is a shareholder of the Company and also serves as a consultant to the Company in connection with the Company’s TBI at its PFNWR subsidiary. The proceeds from the Loan were used for general working capital purposes. The Loan is unsecured, with a term of two years with interest payable at a fixed interest rate of 4.00% per annum. The Loan provides for monthly payments of accrued interest only during the first year of the Loan, with the first interest payment due May 1, 2019 and monthly payments of approximately $208,333 in principal plus accrued interest starting in the second year of the Loan. The Loan also allows for prepayment of principal payments over the term of the Loan without penalty with such prepayment of principal payments to be applied to the second year of the loan payments at the Company’s discretion. Since inception of the loan, the Company has made total prepayments in principal of $936,000, of which $416,000 was made in the first nine months of 2020. In connection with the above Loan, the Lender agreed under the terms of the Loan and a Subordination Agreement with our credit facility lender, to subordinate payment under the Loan, and agreed that the Loan will be junior in right of payment to the credit facility in the event of default or bankruptcy or other insolvency proceeding by us. In connection with this capital raise transaction described above and consideration for us receiving the Loan, the Company issued a Warrant (the “Warrant”) to the Lender to purchase up to 60,000 shares of our Common Stock at an exercise price of $3.51 per share, which was the closing bid price for a share of our Common Stock on NASDAQ.com immediately preceding the execution of the Loan and Warrant. The Warrant expires on April 1, 2024 and remains outstanding at September 30, 2020. As further consideration for this capital raise transaction relating to the Loan, the Company also issued 75,000 shares of its Common Stock to the Lender. The fair value of the Warrant and Common Stock and the related closing fees incurred from the transaction totaled approximately $398,000 and was recorded as debt discount/debt issuance costs, which is being amortized over the term of the loan as interest expense – financing fees. The 75,000 shares of Common Stock, the Warrant and the 60,000 shares of Common Stock that may be purchased under the Warrant were and will be issued in a private placement that was and will be exempt from registration under Rule 506 and/or Sections 4(a)(2) and 4(a)(5) of the Securities Act of 1933, as amended (the “Act”) and bear a restrictive legend against resale except in a transaction registered under the Act or in a transaction exempt from registration thereunder. Upon default, the Lender will have the right to elect to receive in full and complete satisfaction of the Company’s obligations under the Loan either: (a) the cash amount equal to the sum of the unpaid principal balance owing under the loan and all accrued and unpaid interest thereon (the “Payoff Amount”) or (b) upon meeting certain conditions, the number of whole shares of the Company’s Common Stock (the “Payoff Shares”) determined by dividing the Payoff Amount by the dollar amount equal to the closing bid price of our Common Stock on the date immediately prior to the date of default, as reported or quoted on the primary nationally recognized exchange or automated quotation system on which our Common Stock is listed; provided however, that the dollar amount of such closing bid price shall not be less than $3.51, the closing bid price for our Common Stock as disclosed on NASDAQ.com immediately preceding the signing of this loan agreement. If issued, the Payoff Shares will not be registered and the Lender will not be entitled to registration rights with respect to the Payoff Shares. The aggregate number of shares, warrant shares, and Payoff Shares that are or will be issued to the Lender pursuant to the Loan, together with the aggregate shares of the Company’s Common Stock and other voting securities of the Company owned by the Lender or which may be acquired by the Lender as of the date of issuance of the Payoff Shares, shall not exceed the number of shares of the Company’s Common Stock equal to 14.9% of the number of shares of the Company’s Common Stock issued and outstanding as of the date immediately prior to the default, less the number of shares of the Company’s Common Stock owned by the Lender immediately prior to the date of such default plus the number of shares of our Common Stock that may be acquired by the Lender under warrants and/or options outstanding immediately prior to the date of such default. PPP Loan On April 14, 2020, the Company entered into a promissory note with PNC, our credit facility lender, in the amount of approximately $5,666,000 (“PPP Loan”) under the PPP. The PPP was established under the CARES Act and is administered by the U.S. Small Business Administration (“SBA”). On June 5, 2020, the Flexibility Act was signed into law which amended the CARES Act. The note evidencing the PPP Loan contains events of default relating to, among other things, payment defaults, breach of representations and warranties, and provisions of the promissory note. During the third quarter of 2020, the Company repaid approximately $348,000 of the PPP Loan to PNC resulting from clarification made in the loan calculation at the time of the loan origination. Under the terms of the Flexibility Act, the Company can apply for and be granted forgiveness for all or a portion of the PPP Loan. Such forgiveness will be determined, subject to limitations, based on the use of loan proceeds by the Company for eligible payroll costs, mortgage interest, rent and utility costs and the maintenance of employee and compensation levels for the covered period (which is defined as a 24 week period, beginning April 14, 2020, the date in which proceeds from the PPP Loan was disbursed to the Company by PNC). At least 60% of such forgiven amount must be used for eligible payroll costs. On October 5, 2020, the Company applied for forgiveness on repayment of the loan balance as permitted under the program, which is subject to the review and approval of our lender and the SBA. The approval of the loan forgiveness allows for a maximum period of 150 days from the submittal of a complete loan forgiveness application. If all or a portion of the PPP Loan is not forgiven, all or the remaining portion of the loan will be for a term of two years but can be prepaid at any time prior to maturity without any prepayment penalties. The annual interest rate on the PPP Loan is 1.0% and no payments of principal or interest are due until the date that the SBA remits the loan forgiveness amount to our lender. While the Company’s PPP Loan currently has a two year maturity, the Flexibility Act permits the Company to request a five year maturity with our lender which the Company does not expect to request at this time. |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Sep. 30, 2020 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | 10. Commitments and Contingencies Hazardous Waste In connection with our waste management services, we process both hazardous and non-hazardous waste, which we transport to our own, or other, facilities for destruction or disposal. As a result of disposing of hazardous substances, in the event any cleanup is required, we could be a potentially responsible party for the costs of the cleanup notwithstanding any absence of fault on our part. Legal Matters In the normal course of conducting our business, we are involved in various litigation. We are not a party to any litigation or governmental proceeding which our management believes could result in any judgments or fines against us that could would have a material adverse effect on our financial position, liquidity or results of future operations. During July 2020, Tetra Tech EC, Inc. (“Tetra Tech”) filed a complaint in the United States District Court for the Northern District of California against CH2M Hill, Inc. (“CH2M”) and four subcontractors of CH2M, including the Company (“defendants”). The complaint alleges claims for negligence, negligent misrepresentation and equitable indemnification against all defendants related to alleged damages suffered by Tetra Tech in respect of certain draft reports prepared by defendants at the request of the U.S. Navy as part of an investigation and review of certain whistleblower complaints about Tetra Tech’s environmental restoration at the Hunter’s Point Naval Shipyard in San Francisco. CH2M was hired by the Navy in 2016 to review Tetra Tech’s work. CH2M subcontracted with environmental consulting and cleanup firms Battelle Memorial Institute, Cabrera Services, Inc., SC&A, Inc. and the Company to assist with the review, according to the complaint. The complaint alleges that the subject draft reports were prepared negligently and in a biased manner, made public, and caused damage to Tetra Tech’s reputation; triggering related lawsuits and costing it opportunities for both government and commercial contracts. At this time, the Company does not believe it has any liability to Tetra Tech. The Company has provided notice of this lawsuit to our insurance carrier. Our insurance carrier is providing a defense on our behalf in connection with this lawsuit, subject to a $100,000 self-insured retention and the terms and limitations contained in the insurance policy. Insurance The Company has a 25-year finite risk insurance policy entered into in June 2003 (“2003 Closure Policy”) with AIG Specialty Insurance Company (“AIG”), which provides financial assurance to the applicable states for our permitted facilities in the event of unforeseen closure. The 2003 Closure Policy, as amended, provides for a maximum allowable coverage of $28,177,000 which includes available capacity to allow for annual inflation and other performance and surety bond requirements. Total coverage under the 2003 Closure Policy, as amended, was $19,651,000 at September 30, 2020. At September 30, 2020 and December 31, 2019, finite risk sinking funds contributed by the Company related to the 2003 Closure Policy which is included in other long term assets on the accompanying Consolidated Balance Sheets totaled $11,418,000 and $11,307,000, respectively, which included interest earned of $1,947,000 and $1,836,000 on the finite risk sinking funds as of September 30, 2020 and December 31, 2019, respectively. Interest income for the three and nine months ended September 30, 2020 was approximately $28,000 and $111,000, respectively. Interest income for the three and nine months ended September 30, 2019 was approximately $77,000 and $265,000, respectively. If the Company so elects, AIG is obligated to pay us an amount equal to 100% of the finite risk sinking fund account balance in return for complete release of liability from both us and any applicable regulatory agency using this policy as an instrument to comply with financial assurance requirements. Letter of Credits and Bonding Requirements From time to time, the Company is required to post standby letters of credit and various bonds to support contractual obligations to customers and other obligations, including facility closures. At September 30, 2020, the total amount of standby letters of credit outstanding was approximately $3,026,000 and the total amount of bonds outstanding was approximately $45,814,000. |
Discontinued Operations
Discontinued Operations | 9 Months Ended |
Sep. 30, 2020 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Discontinued Operations | 11. Discontinued Operations The Company’s discontinued operations consist of all our subsidiaries included in our Industrial Segment which encompasses subsidiaries divested in 2011 and prior and three previously closed locations. The Company’s discontinued operations had net losses of $67,000 and $156,000 for the three months ended September 30, 2020 and 2019, respectively (net of taxes of $0 for each period) and net losses of $266,000 and $424,000 for the nine months ended September 30, 2020 and 2019, respectively, (net of taxes of $0 for each period). The losses were primarily due to costs incurred in the administration and continued monitoring of our discontinued operations. The Company’s discontinued operations had no revenues for any of the periods noted above. The following table presents the major class of assets of discontinued operations at September 30, 2020 and December 31, 2019. No assets and liabilities were held for sale at each of the periods noted. September 30, December 31, (Amounts in Thousands) 2020 2019 Current assets Other assets $ 17 $ 104 Total current assets 17 104 Long-term assets Property, plant and equipment, net (1) 81 81 Other assets — 36 Total long-term assets 81 117 Total assets $ 98 $ 221 Current liabilities Accounts payable $ 8 $ 8 Accrued expenses and other liabilities 167 169 Environmental liabilities 744 817 Total current liabilities 919 994 Long-term liabilities Closure liabilities 140 134 Environmental liabilities 110 110 Total long-term liabilities 250 244 Total liabilities $ 1,169 $ 1,238 (1) The Company’s discontinued operations included a note receivable in the original amount of approximately $375,000 recorded in May 2016 resulting from the sale of property at our Perma-Fix of Michigan, Inc. (“PFMI”) subsidiary. This note required 60 equal monthly installment payments by the buyer of approximately $7,250 (which includes interest). On July 24, 2020, the purchaser of the property paid off the outstanding note receivable balance of approximately $105,000. |
Operating Segments
Operating Segments | 9 Months Ended |
Sep. 30, 2020 | |
Segment Reporting [Abstract] | |
Operating Segments | 12. Operating Segments In accordance with ASC 280, “Segment Reporting”, the Company defines an operating segment as a business activity: (1) from which we may earn revenue and incur expenses; (2) whose operating results are regularly reviewed by the chief operating decision maker (“CODM”) to make decisions about resources to be allocated to the segment and assess its performance; and (3) for which discrete financial information is available. Our reporting segments are defined as below: TREATMENT SEGMENT, which includes: ● nuclear, low-level radioactive, mixed waste (containing both hazardous and low-level radioactive constituents), hazardous and non-hazardous waste treatment, processing and disposal services primarily through three uniquely licensed and permitted treatment and storage facilities; and ● R&D activities to identify, develop and implement innovative waste processing techniques for problematic waste streams. SERVICES SEGMENT, which includes: ● Technical services, which include: ○ professional radiological measurement and site survey of large government and commercial installations using advanced methods, technology and engineering; ○ integrated Occupational Safety and Health services including IH assessments; hazardous materials surveys, e.g., exposure monitoring; lead and asbestos management/abatement oversight; indoor air quality evaluations; health risk and exposure assessments; health & safety plan/program development, compliance auditing and training services; and OSHA citation assistance; ○ global technical services providing consulting, engineering, project management, waste management, environmental, and decontamination and decommissioning field, technical, and management personnel and services to commercial and government customers; and ○ on-site waste management services to commercial and governmental customers. ● Nuclear services, which include: ○ technology-based services including engineering, decontamination and decommissioning (“D&D”), specialty services and construction, logistics, transportation, processing and disposal; ○ remediation of nuclear licensed and federal facilities and the remediation cleanup of nuclear legacy sites. Such services capability includes: project investigation; radiological engineering; partial and total plant D&D; facility decontamination, dismantling, demolition, and planning; site restoration; logistics; transportation; and emergency response; and ● A company owned equipment calibration and maintenance laboratory that services, maintains, calibrates, and sources (i.e., rental) health physics, IH and customized NIOSH instrumentation. ● A company owned gamma spectroscopy laboratory for the analysis of oil and gas industry solids and liquids. MEDICAL SEGMENT, which includes: R&D of the Company’s medical isotope production technology by our majority-owned Polish subsidiary, Perma-Fix of Medical or the Medical Segment. The Medical Segment has not generated any revenues and all costs incurred are reflected within R&D in the accompanying consolidated financial statements. As previously disclosed, the Medical Segment has substantially reduced its R&D costs and activities due to the need for capital to fund these activities. The Company anticipates that the Medical Segment will not resume full R&D activities until the necessary capital is obtained through its own credit facility or additional equity raise, or obtains partners willing to provide funding for its R&D. Our reporting segments exclude our corporate headquarters and our discontinued operations (see “Note 11 – Discontinued Operations”) which do not generate revenues. The table below presents certain financial information of our operating segments for the three and nine months ended September 30, 2020 and 2019 (in thousands). Segment Reporting for the Quarter Ended September 30, 2020 Treatment Services Medical Segments Total Corporate (1) Consolidated Total Revenue from external customers $ 7,066 $ 23,106 — $ 30,172 $ — $ 30,172 Intercompany revenues 226 6 — 232 — — Gross profit 1,094 3,656 — 4,750 — 4,750 Research and development 49 7 81 137 20 157 Interest income — — — — 28 28 Interest expense (34 ) (3 ) — (37 ) (50 ) (87 ) Interest expense-financing fees — — — — (58 ) (58 ) Depreciation and amortization 373 97 — 470 8 478 Segment income (loss) before income taxes 280 2,813 (81 ) 3,012 (1,664 ) 1,348 Income tax (benefit) expense (170 ) 2 — (168 ) 35 (133 ) Segment income (loss) 450 2,811 (81 ) 3,180 (1,699 ) 1,481 Expenditures for segment assets 95 24 — 119 3 122 (2) Segment Reporting for the Quarter Ended September 30, 2019 Treatment Services Medical Segments Total Corporate (1) Consolidated Total Revenue from external customers $ 10,081 $ 12,454 — $ 22,535 $ — $ 22,535 Intercompany revenues 75 38 — 113 — — Gross profit 3,338 1,819 — 5,157 — 5,157 Research and development 85 — 74 159 6 165 Interest income — — — — 77 77 Interest expense (19 ) (5 ) — (24 ) (75 ) (99 ) Interest expense-financing fees — — — — (69 ) (69 ) Depreciation and amortization 243 79 — 322 6 328 Segment income (loss) before income taxes 2,244 1,193 (74 ) 3,363 (1,413 ) 1,950 Income tax expense 55 — — 55 — 55 Segment income (loss) 2,189 1,193 (74 ) 3,308 (1,413 ) 1,895 Expenditures for segment assets 470 31 — 501 — 501 (3) Segment Reporting for the Nine Months Ended September 30, 2020 Treatment Services Medical Segments Total Corporate (1) Consolidated Total Revenue from external customers $ 24,469 $ 52,610 — $ 77,079 $ — $ 77,079 Intercompany revenues 879 19 — 898 — — Gross profit 5,533 7,167 — 12,700 — 12,700 Research and development 194 119 221 534 64 598 Interest income 1 — — 1 111 112 Interest expense (80 ) (13 ) — (93 ) (213 ) (306 ) Interest expense-financing fees — — — — (187 ) (187 ) Depreciation and amortization 912 259 — 1,171 18 1,189 Segment income (loss) before income taxes 2,577 5,162 (221 ) 7,518 (4,597 ) 2,921 Income tax (benefit) expense (165 ) 2 — (163 ) 35 (128 ) Segment income (loss) 2,742 5,160 (221 ) 7,681 (4,632 ) 3,049 Expenditures for segment assets 1,095 385 — 1,480 8 1,488 (2) Segment Reporting for the Nine Months Ended September 30, 2019 Treatment Services Medical Segments Total Corporate (1) Consolidated Total Revenue from external customers $ 30,079 $ 21,299 — $ 51,378 $ — $ 51,378 Intercompany revenues 83 101 — 184 — — Gross profit 8,921 2,008 — 10,929 — 10,929 Research and development 367 — 228 595 20 615 Interest income — — — — 265 265 Interest expense (66 ) (18 ) — (84 ) (209 ) (293 ) Interest expense-financing fees — — — — (139 ) (139 ) Depreciation and amortization 713 236 — 949 19 968 Segment income (loss) before income taxes 5,731 318 (228 ) 5,821 (4,003 ) 1,818 Income tax expense 99 — — 99 — 99 Segment income (loss) 5,632 318 (228 ) 5,722 (4,003 ) 1,719 Expenditures for segment assets 764 49 — 813 — 813 (3) (1) Amounts reflect the activity for corporate headquarters not included in the segment information. (2) Net of financed amount of $751,000 and $883,000 for the three and nine months ended September 30, 2020, respectively. (3) Net of financed amount of $6,000 and $29,000 for the three and nine months ended September 30, 2019, respectively. |
Income Taxes
Income Taxes | 9 Months Ended |
Sep. 30, 2020 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | 13. Income Taxes The Company had an income tax benefit of $133,000 and income tax expense of $55,000 for continuing operations for the three months ended September 30, 2020 and 2019, respectively and an income tax benefit of $128,000 and income tax expense of $99,000 for the nine months ended September 30, 2020 and 2019, respectively. Our effective tax rates were approximately 9.9% and 2.8% for the three months ended September 30, 2020 and 2019, respectively, and 4.4% and 5.4% for the nine months ended September 30, 2020 and 2019, respectively. The tax benefit and expense for the periods above were comprised of state tax benefit and expense for separate company filing states. The Company’s tax rate for each of the periods discussed above was impacted by the Company’s full valuation on its net deferred tax assets. The income tax benefit for the three and nine months ended September 30, 2020 included refunds from amended state returns filed in separate company filing states. |
Variable Interest Entities (VIE
Variable Interest Entities (VIE) | 9 Months Ended |
Sep. 30, 2020 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Variable Interest Entities ("VIE") | 14. Variable Interest Entities (“VIE”) On May 24, 2019, the Company and Engineering/Remediation Resources Group, Inc. (“ERRG”) entered into an unpopulated joint venture agreement for project work bids within the Company’s Services Segment. The joint venture is doing business as Perma-Fix ERRG, a general partnership. The Company has a 51% partnership interest in the joint venture and ERRG has a 49% partnership interest in the joint venture. Activities under Perma-Fix ERRG did not commence until the first quarter of 2020. The Company determines whether joint ventures in which it has invested meet the criteria of a VIE at the start of each new venture and when a reconsideration event has occurred. A VIE is a legal entity that satisfies any of the following characteristics: (a) the legal entity does not have sufficient equity investment at risk; (b) the equity investors at risk as a group, lack the characteristics of a controlling financial interest; or (c) the legal entity is structured with disproportionate voting rights. The Company consolidates a VIE if it is determined to be the primary beneficiary of the VIE. The primary beneficiary has both the power to direct the activities of the VIE that most significantly impact the entity’s economic performance and the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. Based on the Company’s evaluation of Perma-Fix ERRG and related agreements with Perma-Fix ERRG, the Company determined that Perma-Fix ERRG is a VIE in which we are the primary beneficiary. At September 30, 2020, Perma-Fix ERRG had total assets of $5,302,000 and total liabilities of $5,302,000 which are all recorded as current. |
Deferral of Employment Tax Depo
Deferral of Employment Tax Deposits | 9 Months Ended |
Sep. 30, 2020 | |
Income Tax Disclosure [Abstract] | |
Deferral of Employment Tax Deposits | 15. Deferral of Employment Tax Deposits The CARES Act, as amended by the Flexibility Act which was signed into law on June 5, 2020, provides employers the option to defer the payment of an employer’s share of social security taxes beginning on March 27, 2020 through December 31, 2020 with 50% of the amount of social security taxes deferred to become due on December 31, 2021 with the remaining 50% due on December 31, 2022. The Company elected to defer such taxes starting in mid-April 2020. The Company estimates the remaining payment of approximately $1,225,000 of social security taxes otherwise due in 2020 will be deferred with 50% due by December 31, 2021 and the remaining 50% due by December 31, 2022. At September 30, 2020, the Company has deferred payment of approximately $838,000 in its share of social security taxes, which amount has been included in “other long-term liabilities” in the Company’s Consolidated Balance Sheet at September 30, 2020. |
Employment Agreements and Manag
Employment Agreements and Management Incentive Plan (MIP) | 9 Months Ended |
Sep. 30, 2020 | |
Incentive Stock Options [Member] | |
Employment Agreements and Management Incentive Plan (MIP) | 16. Employment Agreements and Management Incentive Plan (“MIP”) On July 22, 2020, the Company’s Board appointed Richard Grondin to the position of EVP of Waste Treatment Operations and an executive officer of the Company. Mr. Grondin previously held the position of Vice President of Western Operations within our Treatment Segment. Immediately after the appointment of Richard Grondin to the position of EVP of Waste Treatment Operations and an executive officer of the Company, the Company’s Compensation Committee and the Board approved, and the Company entered into, an employment agreement with each of Mark Duff, CEO (the “CEO Employment Agreement”), Dr. Louis Centofanti, EVP of Strategic Initiatives (the “EVP of Strategic Initiatives Employment Agreement”), Ben Naccarato, CFO (the “CFO Employment Agreement”), Andrew Lombardo, EVP of Nuclear and Technical Services (the “EVP of Nuclear and Technical Services Employment Agreement”), and Richard Grondin, EVP of Waste Treatment Operations (the “EVP of Waste Treatment Operations Employment Agreement”), collectively with the CEO Employment Agreement, the EVP of Strategic Initiative Employment Agreement, the CFO Employment Agreement, the EVP of Nuclear and Technical Services Employment Agreement and the EVP of Waste Treatment Operations Employment Agreement, the “New Employment Agreements” and each individually the “New Employment Agreement”. The Company had previously entered into an employment agreement with each of Mark Duff, Dr. Louis Centofanti and Ben Naccarato on September 8, 2017, all three of which were due to expire on September 8, 2020. These three employment agreements dated September 8, 2017 were terminated effective July, 22, 2020. Pursuant to New Employment Agreements, which are effective July 22, 2020, each of these executive officers is provided an annual salary, which annual salary may be increased, but not reduced, from time to time as determined by the Compensation Committee. As a result of Richard Grondin’s promotion to EVP of Waste Treatment and an executive officer of the Company, his annual salary was increased from $208,000 as Vice President of Western Operations within our Treatment Segment to $240,000, effective July 22, 2020. No change was made to the salary of the remaining executive officers for fiscal year 2020. In addition, each of these executive officers is entitled to participate in the Company’s broad-based benefits plans and to certain performance compensation payable under separate Management Incentive Plans (“MIP”) as approved by the Company’s Compensation Committee and the Company’s Board. The Company’s Compensation Committee and the Board approved individual 2020 MIP on January 16, 2020 (which are effective January 1, 2020) for each Mark Duff, Dr. Louis Centofanti, Ben Naccarato and Andrew Lombardo which remains effective for fiscal year 2020. See “MIP” below for the MIP approved by the Compensation Committee and the Board for Richard Grondin. Each of the New Employment Agreements is effective for three years from July 22, 2020 (the “Initial Term”) unless earlier terminated by the Company or by the executive officer. At the end of the Initial Term of each New Employment Agreement, each New Employment Agreement will automatically be extended for one additional year, unless at least six months prior to the expiration of the Initial Term, the Company or the executive officer provides written notice not to extend the terms of the New Employment Agreement. Pursuant to the New Employment Agreements, if the executive officer’s employment is terminated due to death/disability or for cause (as defined in the agreements), the Company will pay to the executive officer or to his estate an amount equal to the sum of any unpaid base salary and accrued unused vacation time through the date of termination and any benefits due to the executive officer under any employee benefit plan (the “Accrued Amounts”) plus any performance compensation payable pursuant to the MIP with respect to the fiscal year immediately preceding the date of termination. If the executive officer terminates his employment for “good reason” (as defined in the agreements) or is terminated by the Company without cause (including any such termination for “good reason” or without cause within 24 months after a Change in Control (as defined in the agreement)), the Company will pay the executive officer the Accrued Amounts, two years of full base salary, and two times the performance compensation (under the MIP) earned with respect to the fiscal year immediately preceding the date of termination provided the performance compensation earned with respect to the fiscal year immediately preceding the date of termination has not been paid. If performance compensation earned with respect to the fiscal year immediately preceding the date of termination has been made to the executive officer, the executive officer will be paid an additional year of the performance compensation earned with respect to the fiscal year immediately preceding the date of termination. If the executive terminates his employment for a reason other than for good reason, the Company will pay to the executive an amount equal to the Accrued Amounts plus any performance compensation payable pursuant to the MIP with respect to the fiscal year immediately preceding the date of termination. If there is a Change in Control (as defined in the agreements), all outstanding stock options to purchase common stock held by the executive officer will immediately become exercisable in full commencing on the date of termination through the original term of the options. In the event of the death of an executive officer, all outstanding stock options to purchase common stock held by the executive officer will immediately become exercisable in full commencing on the date of death, with such options exercisable for the lesser of the original option term or twelve months from the date of the executive officer’s death. In the event an executive officer terminates his employment for “good reason” or is terminated by the Company without cause, all outstanding stock options to purchase common stock held by the executive officer will immediately become exercisable in full commencing on the date of termination, with such options exercisable for the lesser of the original option term or within 60 days from the date of the executive’s date of termination. Severance benefits payable with respect to a termination (other than Accrued Amounts) shall not be payable until the termination constitutes a “separation from service” (as defined under Treasury Regulation Section 1.409A-1(h)). On July 22, 2020, upon the approval of the EVP of Waste Treatment Operations Employment Agreement as discussed above, the Company’s Board and the Company’s Compensation Committee approved a MIP for Richard Grondin effective January 1, 2020, applicable for fiscal 2020. The MIP provides guidelines for the calculation of annual cash incentive-based compensation, subject to Compensation Committee oversight and modification. The MIP awards cash compensation based on achievement of performance thresholds, with the amount of such compensation established as a percentage of the Mr. Grondin’s 2020 annual base salary as the EVP of Waste Treatment Operations. The potential target performance compensation ranges from 5% to 100% ($12,000 to $240,000) of the base salary for the EVP of Waste Treatment Operations, which became effective on July 22, 2020. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 9 Months Ended |
Sep. 30, 2020 | |
Accounting Policies [Abstract] | |
Recently Adopted Accounting Standards | Recently Adopted Accounting Standards In August 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.” ASU 2018-13 improves the disclosure requirements on fair value measurements. ASU 2018-13 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The adoption of ASU No. 2018-13 by the Company effective January 1, 2020 did not have a material impact on the Company’s financial statements or disclosures. In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (“ASU 848”): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” ASU 2020-04 provides optional expedients and exceptions for applying U.S. GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference London Interbank Offered Rate (“LIBOR”) or another rate that is expected to be discontinued. The amendments in the ASU are effective for all entities as of March 12, 2020 through December 31, 2022. The adoption of ASU 2020-04 on March 12, 2020 by the Company did not have a material impact on the Company’s financial statements. The Company will continue to assess the potential impact of this ASU through the effective period. |
Recently Issued Accounting Standards - Not Yet Adopted | Recently Issued Accounting Standards – Not Yet Adopted In June 2016, the FASB issued ASU No. 2016-13, “Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments and subsequent amendments to the initial guidance: ASU 2018-19 “Codification Improvements to Topic 326, Financial Instruments - Credit Losses,” ASU 2019-04 “Codification Improvements to Topic 326, Financial Instruments - Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments,” ASU 2019-05 “Financial Instruments - Credit Losses (Topic 326): Targeted Transition Relief,” ASU 2019-11 “Codification Improvements to Topic 326, Financial Instruments - Credit Losses” and ASU 2020-02, “Financial Instruments—Credit Losses (Topic 326) and Leases (Topic 842)” (collectively, “Topic 326”). Topic 326 introduces an approach, based on expected losses, to estimate credit losses on certain types of financial instruments and modifies the impairment model for available-for-sale debt securities. The new approach to estimating credit losses (referred to as the current expected credit losses model) applies to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables and loans. Entities are required to apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. These ASUs are effective January 1, 2023 for the Company as a smaller reporting company. The Company had expected to early adopt theses ASUs effective January 1, 2020; however, due to the need for reallocation of the Company’s resources to manage COVID-19 related matters, the Company has deferred adoption of theses ASUs effective January 1, 2020 and expect to adopt these ASUs by January 1, 2023. In December 2019, the FASB issued ASU No. 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes,” which is intended to simplify various aspects related to accounting for income taxes. ASU 2019-12 removes certain exceptions to the general principles in Topic 740 and also clarifies and amends existing guidance to improve consistent application. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. The Company does not expect the adoption of this ASU will have a material impact on the Company’s financial statements. In January 2020, the FASB issued ASU 2020-01, “Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815), clarifying the Interactions between Topic 321, Topic 323, and Topic 815.” This guidance addresses accounting for the transition into and out of the equity method and provides clarification of the interaction of rules for equity securities, the equity method of accounting, and forward contracts and purchase options on certain types of securities. This standard is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2020. Early adoption is permitted. The Company does not expect the adoption of this ASU will have a material impact on the Company’s financial statements. In August 2020, the FASB issued ASU No. 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity.” ASU 2020-06 simplifies the accounting for convertible instruments by removing major separation models and removing certain settlement condition qualifiers for the derivatives scope exception for contracts in an entity’s own equity, and simplifies the related diluted net income per share calculation for both Subtopics. ASU 2020-06 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023, for the Company as a smaller reporting company. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is currently evaluating the impact of this ASU on its consolidated financial statements and disclosures. |
Revenue (Tables)
Revenue (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Revenue from Contract with Customer [Abstract] | |
Schedule of Disaggregation of Revenue | The following tables present further disaggregation of our revenues by different categories for our Services and Treatment Segments: Revenue by Contract Type (In thousands) Three Months Ended Three Months Ended September 30, 2020 September 30, 2019 Treatment Services Total Treatment Services Total Fixed price $ 7,066 $ 10,303 $ 17,369 $ 10,081 $ 5,364 $ 15,445 Time and materials — 12,803 12,803 — 7,090 7,090 Total $ 7,066 $ 23,106 $ 30,172 $ 10,081 $ 12,454 $ 22,535 Revenue by Contract Type Nine Months Ended Nine Months Ended (In thousands) September 30, 2020 September 30, 2019 Treatment Services Total Treatment Services Total Fixed price $ 24,469 $ 19,001 $ 43,470 $ 30,079 $ 9,231 $ 39,310 Time and materials — 33,609 33,609 — 12,068 12,068 Total $ 24,469 $ 52,610 $ 77,079 $ 30,079 $ 21,299 $ 51,378 Revenue by generator Three Months Ended Three Months Ended (In thousands) September 30, 2020 September 30, 2019 Treatment Services Total Treatment Services Total Domestic government $ 5,334 $ 21,660 $ 26,994 $ 7,537 $ 10,155 $ 17,692 Domestic commercial 1,598 459 2,057 2,535 475 3,010 Foreign government 134 966 1,100 — 1,804 1,804 Foreign commercial — 21 21 9 20 29 Total $ 7,066 $ 23,106 $ 30,172 $ 10,081 $ 12,454 $ 22,535 Revenue by generator Nine Months Ended Nine Months Ended (In thousands) September 30, 2020 September 30, 2019 Treatment Services Total Treatment Services Total Domestic government $ 19,079 $ 48,249 $ 67,328 $ 21,986 $ 15,683 $ 37,669 Domestic commercial 5,256 1,352 6,608 7,809 2,088 9,897 Foreign government 134 2,945 3,079 220 3,465 3,685 Foreign commercial — 64 64 64 63 127 Total $ 24,469 $ 52,610 $ 77,079 $ 30,079 $ 21,299 $ 51,378 |
Schedule of Contract Assets and Liabilities | The following table represents changes in our contract assets and contract liabilities balances: (In thousands) September 30, 2020 December 31, 2019 Year-to-date Change ($) Year-to-date Change (%) Contract assets Account receivables, net of allowance $ 13,442 $ 13,178 $ 264 2.0 % Unbilled receivables - current 14,366 7,984 6,382 79.9 % Contract liabilities Deferred revenue $ 4,806 $ 5,456 $ (650 ) (11.9 )% |
Leases (Tables)
Leases (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Leases [Abstract] | |
Schedule of Components of Lease Cost | The components of lease cost for the Company’s leases for the three and nine months ended September 30, 2020 and 2019 were as follows (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Operating Leases: Lease cost $ 114 $ 114 $ 342 $ 342 Finance Leases: Amortization of ROU assets 109 20 161 39 Interest on lease liability 47 15 97 40 156 35 258 79 Short-term lease rent expense 3 41 7 113 Total lease cost $ 273 $ 190 $ 607 $ 534 |
Schedule of Weighted Average Lease | The weighted average remaining lease term and the weighted average discount rate for operating and finance leases at September 30, 2020 were: Operating Leases Finance Leases Weighted average remaining lease terms (years) 8.2 3.4 Weighted average discount rate 8.0 % 7.9 % |
Schedule of Operating Lease Liability Maturity | The following table reconciles the undiscounted cash flows for the operating and finance leases at September 30, 2020 to the operating and finance lease liabilities recorded on the balance sheet (in thousands): Operating Leases Finance Leases 2020 Remainder $ 112 $ 263 2021 450 554 2022 458 272 2023 466 149 2024 342 146 2025 and thereafter 1,457 164 Total undiscounted lease payments 3,285 1,548 Less: Imputed interest (879 ) (158 ) Present value of lease payments $ 2,406 $ 1,390 Current portion of operating lease obligations $ 265 $ — Long-term operating lease obligations, less current portion $ 2,141 $ — Current portion of finance lease obligations $ — $ 675 Long-term finance lease obligations, less current portion $ — $ 715 |
Schedule of Finance Lease Liability Maturity | The following table reconciles the undiscounted cash flows for the operating and finance leases at September 30, 2020 to the operating and finance lease liabilities recorded on the balance sheet (in thousands): Operating Leases Finance Leases 2020 Remainder $ 112 $ 263 2021 450 554 2022 458 272 2023 466 149 2024 342 146 2025 and thereafter 1,457 164 Total undiscounted lease payments 3,285 1,548 Less: Imputed interest (879 ) (158 ) Present value of lease payments $ 2,406 $ 1,390 Current portion of operating lease obligations $ 265 $ — Long-term operating lease obligations, less current portion $ 2,141 $ — Current portion of finance lease obligations $ — $ 675 Long-term finance lease obligations, less current portion $ — $ 715 |
Schedule of Supplemental Cash Flow and Other Information Related to Leases | Supplemental cash flow and other information related to our leases were as follows for the three and nine months ended September 30, 2020 and 2019 (in thousands): Three Months Ended Nine Months Ended September 30, September 30, 2020 2019 2020 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flow used in operating leases $ 111 $ 109 $ 331 $ 326 Operating cash flow used in finance leases $ 47 $ 15 $ 97 $ 40 Financing cash flow used in finance leases $ 182 $ 73 $ 411 $ 174 ROU assets obtained in exchange for lease obligations for: Finance liabilities $ 751 $ 390 $ 874 $ 528 Operating liabilities $ — — — 182 |
Intangible Assets (Tables)
Intangible Assets (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Finite-Lived Intangible Assets | The following table summarizes information relating to the Company’s definite-lived intangible assets: Weighted Average September 30, 2020 December 31, 2019 Amortization Gross Net Gross Net Period Carrying Accumulated Carrying Carrying Accumulated Carrying Intangibles (amount in thousands) (Years) Amount Amortization Amount Amount Amortization Amount Patent 9.7 $ 785 $ (375 ) $ 410 $ 760 $ (358 ) $ 402 Software 3 414 (410 ) 4 414 (408 ) 6 Customer relationships 10 3,370 (2,861 ) 509 3,370 (2,713 ) 657 Total $ 4,569 $ (3,646 ) $ 923 $ 4,544 $ (3,479 ) $ 1,065 |
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense | The following table summarizes the expected amortization over the next five years for our definite-lived intangible assets: Amount Year (In thousands) 2020 (remaining) $ 56 2021 202 2022 176 2023 135 2024 13 |
Capital Stock, Stock Plans an_2
Capital Stock, Stock Plans and Stock-Based Compensation (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Share-based Payment Arrangement [Abstract] | |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions | The fair value of the options granted as discussed above and the related assumptions used in the Black-Scholes option model used to value the options granted for the nine months ended September 30, 2020 and 2019 were as follows: Employee Stock Option Granted Nine Months Ended September 30, 2019 Weighted-average fair value per share $ 1.46 Risk -free interest rate (1) 1.4%-2.58 % Expected volatility of stock (2) 48.67%-51.38 % Dividend yield None Expected option life (3) 5.0 years Outside Director Stock Option Granted Nine Months Ended September 30, 2020 2019 Weighted-average fair value per share $ 4.66 $ 2.27 Risk -free interest rate (1) 0.59%-1.61 % 2.08 % Expected volatility of stock (2) 55.83%-56.68 % 54.28 % Dividend yield None None Expected option life (3) 10.0 years 10.0 years (1) The risk-free interest rate is based on the U.S. Treasury yield in effect at the grant date over the expected term of the option. (2) The expected volatility is based on historical volatility from our traded Common Stock over the expected term of the option. (3) The expected option life is based on historical exercises and post-vesting data. |
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs | The following table summarizes stock-based compensation recognized for the three and nine months ended September 30, 2020 and 2019 for our employee and director stock options. Three Months Ended Nine Months Ended Stock Options September 30, September 30, 2020 2019 2020 2019 Employee Stock Options $ 34,000 $ 35,000 $ 99,000 $ 114,000 Director Stock Options 35,000 10,000 62,000 15,000 Total $ 69,000 $ 45,000 $ 161,000 $ 129,000 |
Schedule of Stock Options Roll Forward | The summary of the Company’s total Stock Option Plans as of September 30, 2020 and September 30, 2019, and changes during the periods then ended, are presented below. The Company’s Plans consist of the 2010 Stock Option Plan, the 2017 Plans and the 2003 Plan: Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (years) Aggregate Intrinsic Value (4) Options outstanding January 1, 2020 681,300 $ 3.84 Granted 24,000 $ 6.92 Exercised (12,500 ) $ 3.47 $ 16,060 Forfeited/expired (34,400 ) $ 5.52 Options outstanding end of period (1) 658,400 $ 3.87 3.7 $ 2,096,355 Options exercisable at September 30, 2020 (2) 340,400 $ 4.01 3.6 $ 1,036,255 Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (years) Aggregate Intrinsic Value (4) Options outstanding January 1, 2019 616,000 $ 4.23 Granted 129,500 $ 3.24 Exercised ─ $ ─ Forfeited/expired (31,800 ) $ 8.68 Options outstanding end of period (3) 713,700 $ 3.85 4.4 $ 611,942 Options exercisable as of September 30, 2019 (3) 299,200 $ 4.30 4.0 $ 188,082 (1) (2) (3) (4) |
Income Per Share (Tables)
Income Per Share (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted | The following table reconciles the income (loss) and average share amounts used to compute both basic and diluted income per share: Three Months Ended Nine Months Ended September 30, September 30, (Amounts in Thousands, (Unaudited) (Unaudited) Except for Per Share Amounts) 2020 2019 2020 2019 Net income attributable to Perma-Fix Environmental Services, Inc., common stockholders: Income from continuing operations, net of taxes $ 1,481 1,895 3,049 1,719 Net loss attributable to non-controlling interest (32 ) (29 ) (87 ) (90 ) Income from continuing operations attributable to Perma-Fix Environmental Services, Inc. common stockholders $ 1,513 $ 1,924 $ 3,136 $ 1,809 Loss from discontinuing operations attributable to Perma-Fix Environmental Services, Inc. common stockholders (67 ) (156 ) (266 ) (424 ) Net income attributable to Perma-Fix Environmental Services, Inc. common stockholders $ 1,446 $ 1,768 $ 2,870 $ 1,385 Basic income per share attributable to Perma-Fix Environmental Services, Inc. common stockholders $ .12 $ .15 $ .24 $ .12 Diluted income per share attributable to Perma-Fix Environmental Services, Inc. common stockholders $ .12 $ .15 $ .23 $ .11 Weighted average shares outstanding: Basic weighted average shares outstanding 12,145 12,070 12,134 12,029 Add: dilutive effect of stock options 201 47 181 29 Add: dilutive effect of warrant 25 6 22 3 Diluted weighted average shares outstanding 12,371 12,123 12,337 12,061 Potential shares excluded from above weighted average share calculations due to their anti-dilutive effect include: Stock options 30 159 42 165 Warrant — — — — |
Long Term Debt (Tables)
Long Term Debt (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Debt Disclosure [Abstract] | |
Schedule of Long term Debt | Long-term debt consists of the following at September 30, 2020 and December 31, 2019: (Amounts in Thousands) September 30, 2020 December 31, 2019 Revolving Credit (1) $ — $ 321 Term Loan (1) 1,487 (2) 1,827 (2) Promissory Note (3) 424 (4) 1,732 (4) Promissory Note (3) 5,318 (5) — Note Payable 25 — Total debt 7,254 3,880 Less current portion of long-term debt 828 (4) 1,300 (4) Long-term debt $ 6,426 $ 2,580 (1) (2) (3) (4) (5) Entered into with the Company’s credit facility lender under the Paycheck Protection Program (see “PPP Loan” below for further information on this loan). |
Discontinued Operations (Tables
Discontinued Operations (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Discontinued Operations and Disposal Groups [Abstract] | |
Schedule of Disposal Groups, Including Discontinued Operation Balance Sheet | The following table presents the major class of assets of discontinued operations at September 30, 2020 and December 31, 2019. No assets and liabilities were held for sale at each of the periods noted. September 30, December 31, (Amounts in Thousands) 2020 2019 Current assets Other assets $ 17 $ 104 Total current assets 17 104 Long-term assets Property, plant and equipment, net (1) 81 81 Other assets — 36 Total long-term assets 81 117 Total assets $ 98 $ 221 Current liabilities Accounts payable $ 8 $ 8 Accrued expenses and other liabilities 167 169 Environmental liabilities 744 817 Total current liabilities 919 994 Long-term liabilities Closure liabilities 140 134 Environmental liabilities 110 110 Total long-term liabilities 250 244 Total liabilities $ 1,169 $ 1,238 (1) net of accumulated depreciation of $10,000 for each period presented. |
Operating Segments (Tables)
Operating Segments (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Segment Reporting [Abstract] | |
Schedule of Segment Reporting Information | The table below presents certain financial information of our operating segments for the three and nine months ended September 30, 2020 and 2019 (in thousands). Segment Reporting for the Quarter Ended September 30, 2020 Treatment Services Medical Segments Total Corporate (1) Consolidated Total Revenue from external customers $ 7,066 $ 23,106 — $ 30,172 $ — $ 30,172 Intercompany revenues 226 6 — 232 — — Gross profit 1,094 3,656 — 4,750 — 4,750 Research and development 49 7 81 137 20 157 Interest income — — — — 28 28 Interest expense (34 ) (3 ) — (37 ) (50 ) (87 ) Interest expense-financing fees — — — — (58 ) (58 ) Depreciation and amortization 373 97 — 470 8 478 Segment income (loss) before income taxes 280 2,813 (81 ) 3,012 (1,664 ) 1,348 Income tax (benefit) expense (170 ) 2 — (168 ) 35 (133 ) Segment income (loss) 450 2,811 (81 ) 3,180 (1,699 ) 1,481 Expenditures for segment assets 95 24 — 119 3 122 (2) Segment Reporting for the Quarter Ended September 30, 2019 Treatment Services Medical Segments Total Corporate (1) Consolidated Total Revenue from external customers $ 10,081 $ 12,454 — $ 22,535 $ — $ 22,535 Intercompany revenues 75 38 — 113 — — Gross profit 3,338 1,819 — 5,157 — 5,157 Research and development 85 — 74 159 6 165 Interest income — — — — 77 77 Interest expense (19 ) (5 ) — (24 ) (75 ) (99 ) Interest expense-financing fees — — — — (69 ) (69 ) Depreciation and amortization 243 79 — 322 6 328 Segment income (loss) before income taxes 2,244 1,193 (74 ) 3,363 (1,413 ) 1,950 Income tax expense 55 — — 55 — 55 Segment income (loss) 2,189 1,193 (74 ) 3,308 (1,413 ) 1,895 Expenditures for segment assets 470 31 — 501 — 501 (3) Segment Reporting for the Nine Months Ended September 30, 2020 Treatment Services Medical Segments Total Corporate (1) Consolidated Total Revenue from external customers $ 24,469 $ 52,610 — $ 77,079 $ — $ 77,079 Intercompany revenues 879 19 — 898 — — Gross profit 5,533 7,167 — 12,700 — 12,700 Research and development 194 119 221 534 64 598 Interest income 1 — — 1 111 112 Interest expense (80 ) (13 ) — (93 ) (213 ) (306 ) Interest expense-financing fees — — — — (187 ) (187 ) Depreciation and amortization 912 259 — 1,171 18 1,189 Segment income (loss) before income taxes 2,577 5,162 (221 ) 7,518 (4,597 ) 2,921 Income tax (benefit) expense (165 ) 2 — (163 ) 35 (128 ) Segment income (loss) 2,742 5,160 (221 ) 7,681 (4,632 ) 3,049 Expenditures for segment assets 1,095 385 — 1,480 8 1,488 (2) Segment Reporting for the Nine Months Ended September 30, 2019 Treatment Services Medical Segments Total Corporate (1) Consolidated Total Revenue from external customers $ 30,079 $ 21,299 — $ 51,378 $ — $ 51,378 Intercompany revenues 83 101 — 184 — — Gross profit 8,921 2,008 — 10,929 — 10,929 Research and development 367 — 228 595 20 615 Interest income — — — — 265 265 Interest expense (66 ) (18 ) — (84 ) (209 ) (293 ) Interest expense-financing fees — — — — (139 ) (139 ) Depreciation and amortization 713 236 — 949 19 968 Segment income (loss) before income taxes 5,731 318 (228 ) 5,821 (4,003 ) 1,818 Income tax expense 99 — — 99 — 99 Segment income (loss) 5,632 318 (228 ) 5,722 (4,003 ) 1,719 Expenditures for segment assets 764 49 — 813 — 813 (3) (1) Amounts reflect the activity for corporate headquarters not included in the segment information. (2) Net of financed amount of $751,000 and $883,000 for the three and nine months ended September 30, 2020, respectively. (3) Net of financed amount of $6,000 and $29,000 for the three and nine months ended September 30, 2019, respectively. |
COVID-19 Impact (Details Narrat
COVID-19 Impact (Details Narrative) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | Dec. 31, 2019 | |
Net revenues | $ 30,172 | $ 22,535 | $ 77,079 | $ 51,378 | |
Cash on hand | 4,811 | 4,811 | $ 390 | ||
Borrowing availability of credit facility | $ 16,404 | 16,404 | |||
Service Segment [Member] | |||||
Net revenues | $ 10,652 |
Revenue (Details Narrative)
Revenue (Details Narrative) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Revenue from Contract with Customer [Abstract] | ||||
Revenue recognized | $ 1,134 | $ 1,877 | $ 7,673 | $ 9,322 |
Revenue - Schedule of Disaggreg
Revenue - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Net revenues | $ 30,172 | $ 22,535 | $ 77,079 | $ 51,378 |
Fixed Price [Member] | ||||
Net revenues | 17,369 | 15,445 | 43,470 | 39,310 |
Time and Materials [Member] | ||||
Net revenues | 12,803 | 7,090 | 33,609 | 12,068 |
Treatment [Member] | ||||
Net revenues | 7,066 | 10,081 | 24,469 | 30,079 |
Treatment [Member] | Fixed Price [Member] | ||||
Net revenues | 7,066 | 10,081 | 24,469 | 30,079 |
Treatment [Member] | Time and Materials [Member] | ||||
Net revenues | ||||
Services [Member] | ||||
Net revenues | 23,106 | 12,454 | 52,610 | 21,299 |
Services [Member] | Fixed Price [Member] | ||||
Net revenues | 10,303 | 5,364 | 19,001 | 9,231 |
Services [Member] | Time and Materials [Member] | ||||
Net revenues | 12,803 | 7,090 | 33,609 | 12,068 |
Domestic Government [Member] | ||||
Net revenues | 26,994 | 17,692 | 67,328 | 37,669 |
Domestic Government [Member] | Treatment [Member] | ||||
Net revenues | 5,334 | 7,537 | 19,079 | 21,986 |
Domestic Government [Member] | Services [Member] | ||||
Net revenues | 21,660 | 10,155 | 48,249 | 15,683 |
Domestic Commercial [Member] | ||||
Net revenues | 2,057 | 3,010 | 6,608 | 9,897 |
Domestic Commercial [Member] | Treatment [Member] | ||||
Net revenues | 1,598 | 2,535 | 5,256 | 7,809 |
Domestic Commercial [Member] | Services [Member] | ||||
Net revenues | 459 | 475 | 1,352 | 2,088 |
Foreign Government [Member] | ||||
Net revenues | 1,100 | 1,804 | 3,079 | 3,685 |
Foreign Government [Member] | Treatment [Member] | ||||
Net revenues | 134 | 134 | 220 | |
Foreign Government [Member] | Services [Member] | ||||
Net revenues | 966 | 1,804 | 2,945 | 3,465 |
Foreign Commercial [Member] | ||||
Net revenues | 21 | 29 | 64 | 127 |
Foreign Commercial [Member] | Treatment [Member] | ||||
Net revenues | 9 | 64 | ||
Foreign Commercial [Member] | Services [Member] | ||||
Net revenues | $ 21 | $ 20 | $ 64 | $ 63 |
Revenue - Schedule of Contract
Revenue - Schedule of Contract Assets and Liabilities (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2020 | Dec. 31, 2019 | |
Account receivables, net of allowance | $ 13,442 | $ 13,178 |
Unbilled receivables - current | 14,366 | 7,984 |
Deferred revenue | 4,806 | $ 5,456 |
Year-to-date Change [Member] | ||
Account receivables, net of allowance | 264 | |
Unbilled receivables - current | 6,382 | |
Deferred revenue | $ (650) | |
Changes in Account receivables, net of allowance, percentage | 2.00% | |
Changes in Unbilled receivables - current, percentage | 79.90% | |
Changes in Deferred revenue, percentage | (11.90%) |
Leases (Details Narrative)
Leases (Details Narrative) | Sep. 30, 2020 |
Minimum [Member] | |
Operating leases remaining term | 3 years |
Maximum [Member] | |
Operating leases remaining term | 10 years |
Leases - Schedule of Components
Leases - Schedule of Components of Lease Cost (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Leases [Abstract] | ||||
Operating Lease cost | $ 114 | $ 114 | $ 342 | $ 342 |
Finance Leases: Amortization of ROU assets | 109 | 20 | 161 | 39 |
Finance Leases: Interest on lease liability | 47 | 15 | 97 | 40 |
Finance Leases | 156 | 35 | 258 | 79 |
Short-term lease rent expense | 3 | 41 | 7 | 113 |
Total lease cost | $ 273 | $ 190 | $ 607 | $ 534 |
Leases - Schedule of Weighted A
Leases - Schedule of Weighted Average Lease (Details) | Sep. 30, 2020 |
Leases [Abstract] | |
Operating Leases, Weighted average remaining lease terms (years) | 8 years 2 months 12 days |
Operating Leases, Weighted average discount rate | 8.00% |
Finance Leases, Weighted average remaining lease terms (years) | 3 years 4 months 24 days |
Finance Leases, Weighted average discount rate | 7.90% |
Leases - Schedule of Operating
Leases - Schedule of Operating Lease Liability Maturity (Details) - USD ($) $ in Thousands | Sep. 30, 2020 | Dec. 31, 2019 |
Leases [Abstract] | ||
Operating Leases 2020 Remainder | $ 112 | |
Operating Leases 2021 | 450 | |
Operating Leases 2022 | 458 | |
Operating Leases 2023 | 466 | |
Operating Leases 2024 | 342 | |
Operating Leases 2025 and thereafter | 1,457 | |
Operating Leases Total undiscounted lease payments | 3,285 | |
Operating Leases Less: Imputed interest | (879) | |
Operating Leases Present value of lease payments | 2,406 | |
Current portion of operating lease obligations | 265 | $ 244 |
Long-term operating lease obligations, less current portion | $ 2,141 | $ 2,342 |
Leases - Schedule of Finance Le
Leases - Schedule of Finance Lease Liability Maturity (Details) - USD ($) $ in Thousands | Sep. 30, 2020 | Dec. 31, 2019 |
Leases [Abstract] | ||
Finance Leases 2020 Remainder | $ 263 | |
Finance Leases 2021 | 554 | |
Finance Leases 2022 | 272 | |
Finance Leases 2023 | 149 | |
Finance Leases 2024 | 146 | |
Finance Leases 2025 and thereafter | 164 | |
Finance Leases Total undiscounted lease payments | 1,548 | |
Finance Leases Less: Imputed interest | (158) | |
Finance Leases Present value of lease payments | 1,390 | |
Current portion of finance lease obligations | 675 | $ 471 |
Long-term finance lease obligations, less current portion | $ 715 | $ 466 |
Leases - Schedule of Supplement
Leases - Schedule of Supplemental Cash Flow and Other Information Related to Leases (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Leases [Abstract] | ||||
Operating cash flow used in operating leases | $ 111 | $ 109 | $ 331 | $ 326 |
Operating cash flow used in finance leases | 47 | 15 | 97 | 40 |
Financing cash flow used in finance leases | 182 | 73 | 411 | 174 |
ROU assets obtained in exchange for lease obligations for finance liabilities | 751 | 390 | 874 | 528 |
ROU assets obtained in exchange for lease obligations for operating liabilities | $ 182 |
Intangible Assets (Details Narr
Intangible Assets (Details Narrative) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ||||
Amortization expense of intangible asset | $ 58 | $ 60 | $ 167 | $ 194 |
Intangible Assets - Schedule of
Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands | 9 Months Ended | |
Sep. 30, 2020 | Dec. 31, 2019 | |
Gross Carrying Amount | $ 4,569 | $ 4,544 |
Accumulated Amortization | (3,646) | (3,479) |
Finite-Lived Intangible Assets, Net | $ 923 | 1,065 |
Patent [Member] | ||
Weighted Average Amortization Period (Years) | 9 years 8 months 12 days | |
Gross Carrying Amount | $ 785 | 760 |
Accumulated Amortization | (375) | (358) |
Finite-Lived Intangible Assets, Net | $ 410 | 402 |
Software [Member] | ||
Weighted Average Amortization Period (Years) | 3 years | |
Gross Carrying Amount | $ 414 | 414 |
Accumulated Amortization | (410) | (408) |
Finite-Lived Intangible Assets, Net | $ 4 | 6 |
Customer Relationships [Member] | ||
Weighted Average Amortization Period (Years) | 10 years | |
Gross Carrying Amount | $ 3,370 | 3,370 |
Accumulated Amortization | (2,861) | (2,713) |
Finite-Lived Intangible Assets, Net | $ 509 | $ 657 |
Intangible Assets - Schedule _2
Intangible Assets - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) - Intangible Assets [Member] $ in Thousands | Sep. 30, 2020USD ($) |
2020 (remaining) | $ 56 |
2021 | 202 |
2022 | 176 |
2023 | 135 |
2024 | $ 13 |
Capital Stock, Stock Plans an_3
Capital Stock, Stock Plans and Stock-Based Compensation (Details Narrative) - USD ($) | Aug. 10, 2020 | Jul. 22, 2020 | Mar. 27, 2020 | Feb. 04, 2020 | Aug. 29, 2019 | Jul. 25, 2019 | Jan. 17, 2019 | Jul. 27, 2017 | May 31, 2018 | Sep. 30, 2020 | Sep. 30, 2019 |
Unrecognized compensation cost related to unvested options consultant | $ 349,000 | ||||||||||
Unrecognized compensation expected term | 2 years 1 month 6 days | ||||||||||
Proceeds from exercise of stock options | $ 6,000 | ||||||||||
Ferguson Stock Option [Member] | |||||||||||
Options to purchase shares of common stock | 60,000 | 30,000 | |||||||||
Options extended date description | The Compensation Committee and the Board approved another amendment to the Ferguson Stock Option whereby the vesting date for the second milestone was further extended to December 31, 2021 from March 31, 2020 and the vesting date for the third milestone for the purchase of up to 60,000 shares of the Company's Common Stock was extended to December 31, 2022 from January 27, 2021. | The Company's Common Stock was extended to March 31, 2020 from January 27, 2019 | |||||||||
Robert Ferguson [Member] | |||||||||||
Number of options exercised | 10,000 | ||||||||||
Unrecognized compensation cost related to unvested options consultant | $ 262,000 | ||||||||||
Remaining stock option | 90,000 | ||||||||||
2003 Outside Directors Stock Plan [Member] | |||||||||||
Number of stock option shares granted | 6,000 | ||||||||||
Stock options granted contractual term | 10 years | ||||||||||
Stock options granted vesting period | 6 months | ||||||||||
Stock options, exercise price | $ 7.29 | ||||||||||
2003 Plan [Member] | |||||||||||
Number of stock option shares granted | 12,000 | 6,000 | 12,000 | ||||||||
Stock options granted contractual term | 10 years | 10 years | 10 years | ||||||||
Stock options granted vesting period | 6 months | 6 months | 6 months | ||||||||
Stock options, exercise price | $ 6.70 | $ 7 | $ 3.31 | ||||||||
2017 Plan [Member] | |||||||||||
Number of stock option shares granted | 12,500 | ||||||||||
Stock options granted contractual term | 6 years | ||||||||||
Stock options, exercise price | $ 3.90 | ||||||||||
2017 Plan [Member] | One-Fifth Vesting [Member] | |||||||||||
Stock options granted vesting period | 5 years | ||||||||||
2017 Stock Option Plan [Member] | |||||||||||
Number of stock option shares granted | 105,000 | ||||||||||
Stock options granted contractual term | 6 years | ||||||||||
Stock options, exercise price | $ 3.15 | ||||||||||
2017 Stock Option Plan [Member] | One-Fifth Vesting [Member] | |||||||||||
Stock options granted vesting period | 5 years | ||||||||||
2017 Stock Option Plan [Member] | Executive Officers [Member] | |||||||||||
Number of stock option shares granted | 55,000 | ||||||||||
2017 Stock Option Plan [Member] | Consultant [Member] | |||||||||||
Number of stock option shares granted | 100,000 | ||||||||||
Stock options, exercise price | $ 3.65 | ||||||||||
2003 Outside Directors Stock Plan [Member] | |||||||||||
Stock issued during period for services, shares | 24,959 | ||||||||||
Allocated share-based compensation expense | $ 179,000 | ||||||||||
2017 Stock Option Plan [Member] | Employee [Member] | |||||||||||
Number of options exercised | 2,000 | ||||||||||
Proceeds from exercise of stock options | $ 6,300 | ||||||||||
2017 Stock Option Plan [Member] | Former Employee [Member] | |||||||||||
Number of shares issued from option exercise (cashless) | 1,884 | ||||||||||
2017 Stock Option Plan [Member] | Former Employee [Member] | First Separate Options [Member] | |||||||||||
Stock options, exercise price | $ 3.60 | ||||||||||
Number of options exercised | 8,000 | ||||||||||
2017 Stock Option Plan [Member] | Former Employee [Member] | Second Separate Options [Member] | |||||||||||
Stock options, exercise price | $ 3.15 | ||||||||||
Number of options exercised | 2,500 |
Capital Stock, Stock Plans an_4
Capital Stock, Stock Plans and Stock-Based Compensation - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) - $ / shares | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | ||
Employee Stock Option Granted [Member] | |||
Weighted-average fair value per option | $ 1.46 | ||
Dividend yield | 0.00% | ||
Expected option life | [1] | 5 years | |
Employee Stock Option Granted [Member] | Maximum [Member] | |||
Risk -free interest rate | [2] | 2.58% | |
Expected volatility of stock | [3] | 51.38% | |
Employee Stock Option Granted [Member] | Minimum [Member] | |||
Risk -free interest rate | [2] | 1.40% | |
Expected volatility of stock | [3] | 48.67% | |
Outside Director Stock Options Granted [Member] | |||
Weighted-average fair value per option | $ 4.66 | $ 2.27 | |
Risk -free interest rate | [2] | 2.08% | |
Expected volatility of stock | [3] | 54.28% | |
Dividend yield | 0.00% | 0.00% | |
Expected option life | [1] | 10 years | 10 years |
Outside Director Stock Options Granted [Member] | Maximum [Member] | |||
Risk -free interest rate | [2] | 1.61% | |
Expected volatility of stock | [3] | 56.68% | |
Outside Director Stock Options Granted [Member] | Minimum [Member] | |||
Risk -free interest rate | [2] | 0.59% | |
Expected volatility of stock | [3] | 55.83% | |
[1] | The expected option life is based on historical exercises and post-vesting data. | ||
[2] | The risk-free interest rate is based on the U.S. Treasury yield in effect at the grant date over the expected term of the option. | ||
[3] | The expected volatility is based on historical volatility from our traded Common Stock over the expected term of the option. |
Capital Stock, Stock Plans an_5
Capital Stock, Stock Plans and Stock-Based Compensation - Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Stock-based compensation | $ 69 | $ 45 | $ 161 | $ 129 |
Employee Stock Options [Member] | ||||
Stock-based compensation | 34 | 35 | 99 | 114 |
Director Stock Options [Member] | ||||
Stock-based compensation | $ 35 | $ 10 | $ 62 | $ 15 |
Capital Stock, Stock Plans an_6
Capital Stock, Stock Plans and Stock-Based Compensation - Schedule of Stock Options Roll Forward (Details) - Stock Option [Member] - USD ($) | 9 Months Ended | ||||
Sep. 30, 2020 | Sep. 30, 2019 | ||||
Shares Options Outstanding Beginning | 681,300 | 616,000 | |||
Shares Options Granted | 24,000 | 129,500 | |||
Shares Options Exercised | (12,500) | ||||
Shares Options Forfeited/expired | (34,400) | (31,800) | |||
Shares Options Outstanding Ending | 654,800 | [1] | 713,700 | [2] | |
Shares Options Exercisable | 340,400 | [3] | 299,200 | [2] | |
Weighted Average Exercise Price Options Outstanding Beginning | $ 3.84 | $ 4.23 | |||
Weighted Average Exercise Price Options Granted | 6.92 | 3.24 | |||
Weighted Average Exercise Price Options Exercised | 3.47 | ||||
Weighted Average Exercise Price Options Forfeited/expired | 5.52 | 8.68 | |||
Weighted Average Exercise Price Options Outstanding Ending | 3.87 | [1] | 3.85 | [2] | |
Weighted Average Exercise Price Options Exercisable | $ 4.01 | [3] | $ 4.30 | [2] | |
Weighted Average Remaining Contractual Term Outstanding | 3 years 8 months 12 days | [1] | 4 years 4 months 24 days | [2] | |
Weighted Average Remaining Contractual Term Exercisable | 3 years 7 months 6 days | [3] | 4 years | [2] | |
Aggregate Intrinsic Value Options Exercised | [4] | $ 16,060 | |||
Aggregate Intrinsic Value Options Outstanding | [4] | 2,096,355 | [1] | $ 611,942 | [2] |
Aggregate Intrinsic Value Options Exercisable | [4] | $ 1,036,255 | [3] | $ 188,082 | [2] |
[1] | Options with exercise prices ranging from $2.79 to $7.29 | ||||
[2] | Options with exercise prices ranging from $2.79 to $13.35 | ||||
[3] | Options with exercise prices ranging from $2.79 to $7.05 | ||||
[4] | The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price. |
Capital Stock, Stock Plans an_7
Capital Stock, Stock Plans and Stock-Based Compensation - Schedule of Stock Options Roll Forward (Details) (Parenthetical) - Stock Option [Member] - $ / shares | 9 Months Ended | |
Sep. 30, 2020 | Sep. 30, 2019 | |
Stock option exercise price per share lower limit | $ 2.79 | $ 2.79 |
Stock option exercise price per share upper limit | 7.29 | $ 13.35 |
Stock option exercise price per share upper limit One | $ 7.05 |
Income Per Share - Schedule of
Income Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Earnings Per Share [Abstract] | ||||
Income from continuing operations, net of taxes | $ 1,481 | $ 1,895 | $ 3,049 | $ 1,719 |
Net loss attributable to non-controlling interest | 32 | 29 | 87 | 90 |
Income from continuing operations attributable to Perma-Fix Environmental Services, Inc. common stockholders | 1,513 | 1,924 | 3,136 | 1,809 |
Loss from discontinuing operations attributable to Perma-Fix Environmental Services, Inc. common stockholders | (67) | (156) | (266) | (424) |
Net income attributable to Perma-Fix Environmental Services, Inc. common stockholders | $ 1,446 | $ 1,768 | $ 2,870 | $ 1,385 |
Basic income per share attributable to Perma-Fix Environmental Services, Inc. common stockholders | $ 0.12 | $ 0.15 | $ 0.24 | $ 0.12 |
Diluted income per share attributable to Perma-Fix Environmental Services, Inc. common stockholders | $ .12 | $ .15 | $ .23 | $ .11 |
Basic weighted average shares outstanding | 12,145 | 12,070 | 12,134 | 12,029 |
Add: dilutive effect of stock options | 201,000 | 47,000 | 181,000 | 29,000 |
Add: dilutive effect of warrants | 25,000 | 6,000 | 22,000 | 3,000 |
Diluted weighted average shares outstanding | 12,371 | 12,123 | 12,337 | 12,061 |
Potential shares excluded from above weighted average share calculations due to their anti-dilutive effect include: Stock options | 30,000 | 159,000 | 42,000 | 165,000 |
Potential shares excluded from above weighted average share calculations due to their anti-dilutive effect include: Warrant |
Long Term Debt (Details Narrati
Long Term Debt (Details Narrative) - USD ($) | May 08, 2020 | Apr. 14, 2020 | Apr. 02, 2019 | Oct. 31, 2011 | Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | Dec. 31, 2019 | |
Long-term debt | $ 7,254,000 | $ 7,254,000 | $ 3,880,000 | |||||||
Fixed charge coverage ratio | Upon the achievement of a FCCR of greater than 1.25:1 | |||||||||
Loss on extinguishment of debt | (27,000) | |||||||||
Line of credit facility, remaining borrowing capacity | 16,404,000 | 16,404,000 | ||||||||
Letters of credit outstanding, amount | 3,026,000 | 3,026,000 | ||||||||
Prepayments in principal amount | 416,000 | 520,000 | ||||||||
Debt discount and debt issuance costs | (99,000) | (99,000) | (248,000) | |||||||
Repayments of loan debt | 1,457,000 | |||||||||
New Loan Agreement [Member] | ||||||||||
Debt instrument maturity date | May 15, 2024 | |||||||||
Minimum tangible adjusted net worth requirement | $ 27,000,000 | |||||||||
Fixed charge coverage ratio | Minimum FCCR requirement of 1.15:1 | |||||||||
Indirect cost including legal fees | $ 35,000 | |||||||||
Loss on extinguishment of debt | 27,000 | |||||||||
New Loan Agreement [Member] | Lender [Member] | ||||||||||
Debt instrument fees | 50,000 | |||||||||
New Loan Agreement [Member] | Maximum [Member] | ||||||||||
Capital spending maximum | $ 6,000,000 | |||||||||
Loan and Securities Purchase Agreement, Promissory Note and Subordination Agreement [Member] | ||||||||||
Long-term debt | $ 2,500,000 | |||||||||
Debt instrument, interest rate, stated percentage | 4.00% | |||||||||
Debt instrument, first required interest payment | May 1, 2019 | |||||||||
Debt instrument, periodic payment, principal | $ 208,333 | |||||||||
Prepayments in principal amount | $ 936,000 | |||||||||
Warrants to purchase share of common stock | 60,000 | |||||||||
Warrants exercise price | $ 3.51 | |||||||||
Debt discount and debt issuance costs | $ 398,000 | |||||||||
Common stock, minimum closing bid price per share | $ 3.51 | |||||||||
Common stock issued percentage | 14.90% | |||||||||
Loan and Securities Purchase Agreement, Promissory Note and Subordination Agreement [Member] | Private Placement [Member] | ||||||||||
Warrants to purchase share of common stock | 60,000 | |||||||||
Shares issued to lender | 75,000 | |||||||||
London Interbank Offered Rate (LIBOR) [Member] | ||||||||||
Debt Instrument, basis spread on variable rate | 0.75% | |||||||||
Term Loan [Member] | ||||||||||
Long-term debt | [1],[2] | 1,487,000 | $ 1,487,000 | $ 1,827,000 | ||||||
Term Loan [Member] | Prime [Member] | New Loan Agreement [Member] | ||||||||||
Debt Instrument, basis spread on variable rate | 3.00% | |||||||||
Term Loan [Member] | Prime [Member] | Upon the achievement of a FCCR of greater than 1.25:1 [Member] | ||||||||||
Debt Instrument, basis spread on variable rate | 2.50% | |||||||||
Term Loan [Member] | London Interbank Offered Rate (LIBOR) [Member] | New Loan Agreement [Member] | ||||||||||
Debt Instrument, basis spread on variable rate | 4.00% | |||||||||
Term Loan [Member] | London Interbank Offered Rate (LIBOR) [Member] | Upon the achievement of a FCCR of greater than 1.25:1 [Member] | ||||||||||
Debt Instrument, basis spread on variable rate | 3.50% | |||||||||
PNC Bank [Member] | New Loan Agreement [Member] | On or Before May 7, 2021 [Member] | ||||||||||
Financing fee percentage | 1.00% | |||||||||
PNC Bank [Member] | New Loan Agreement [Member] | After May 7, 2021 But Prior to or On May 7, 2022 [Member] | ||||||||||
Financing fee percentage | 0.50% | |||||||||
Revised Loan Agreement [Member] | PNC Bank [Member] | Term Loan [Member] | ||||||||||
Long-term debt | $ 6,100,000 | |||||||||
Term Loan Agreement [Member] | Prime [Member] | ||||||||||
Debt Instrument, basis spread on variable rate | 2.50% | |||||||||
Paycheck Protection Program Loan [Member] | Lender [Member] | ||||||||||
Debt instrument, interest rate, stated percentage | 1.00% | |||||||||
Loan amount | $ 5,666,000 | |||||||||
Repayments of loan debt | $ 348,000 | |||||||||
Revolving Credit Facility [Member] | ||||||||||
Line of credit facility, remaining borrowing capacity | 16,404,000 | $ 16,404,000 | ||||||||
Letters of credit outstanding, amount | 3,026,000 | $ 3,026,000 | ||||||||
Revolving Credit Facility [Member] | Prime [Member] | ||||||||||
Debt Instrument, basis spread on variable rate | 3.25% | |||||||||
Revolving Credit Facility [Member] | Prime [Member] | New Loan Agreement [Member] | ||||||||||
Debt Instrument, basis spread on variable rate | 2.50% | |||||||||
Revolving Credit Facility [Member] | Prime [Member] | Upon the achievement of a FCCR of greater than 1.25:1 [Member] | ||||||||||
Debt Instrument, basis spread on variable rate | 2.00% | |||||||||
Revolving Credit Facility [Member] | Plus [Member] | ||||||||||
Debt Instrument, basis spread on variable rate | 2.00% | |||||||||
Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | New Loan Agreement [Member] | ||||||||||
Debt Instrument, basis spread on variable rate | 3.50% | |||||||||
Fixed charge coverage ratio | The Company can only elect to use the LIBOR interest payment option after it becomes compliant with meeting the minimum FCCR of 1.15:1 | |||||||||
Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member] | Upon the achievement of a FCCR of greater than 1.25:1 [Member] | ||||||||||
Debt Instrument, basis spread on variable rate | 3.00% | |||||||||
Revolving Credit Facility [Member] | Revised Loan Agreement [Member] | PNC Bank [Member] | ||||||||||
Line of credit facility, maximum borrowing capacity | $ 12,000,000 | |||||||||
Debt instrument maturity date | Mar. 24, 2021 | |||||||||
Revolving Credit Facility [Member] | Term Loan Agreement [Member] | ||||||||||
Long-term debt | $ 1,741,818 | $ 1,741,818 | ||||||||
Annual rate of interest description | Payment of annual rate of interest due on the revolving credit under the Revised Loan Agreement was at prime (3.25 at September 30, 2020) plus 2% and the term loan at prime plus 2.5%. | |||||||||
Monthly installments | $ 35,547 | |||||||||
[1] | Net of debt issuance costs of ($113,000) and ($92,000) at September 30, 2020 and December 31, 2019, respectively. | |||||||||
[2] | Our revolving credit facility is collateralized by our accounts receivable and our term loan is collateralized by our property, plant, and equipment. Effective July 1, 2019, monthly installment principal payment on the Term Loan was amended to approximately $35,500 from approximately $101,600. See "Revolving Credit and Term Loan Agreement" below for terms of the Company's credit facility prior to the New Loan Agreement dated May 8, 2020. |
Long Term Debt - Schedule of Lo
Long Term Debt - Schedule of Long term Debt (Details) - USD ($) $ in Thousands | Sep. 30, 2020 | Dec. 31, 2019 | ||
Total debt | $ 7,254 | $ 3,880 | ||
Less current portion of long-term debt | [1] | 828 | 1,300 | |
Long-term debt | 6,426 | 2,580 | ||
Revolving Credit [Member] | ||||
Total debt | [2] | 321 | ||
Term Loan [Member] | ||||
Total debt | [2],[3] | 1,487 | 1,827 | |
Promissory Note [Member] | ||||
Total debt | [1],[4] | 424 | 1,732 | |
Promissory Note [Member] | ||||
Total debt | [4] | 5,318 | [5] | |
Note Payable [Member] | ||||
Total debt | $ 25 | |||
[1] | Net of debt discount/debt issuance costs of ($99,000) and ($248,000) at September 30, 2020 and December 31, 2019, respectively. The Promissory Note provides for prepayment of principal over the term of the Note without penalty. In 2019, the Company made total prepayment of principal of $520,000 which was reflected in the current portion of the debt. During the first nine months of 2020, the Company made total principal repayment of $1,457,000 of which $416,000 was prepaid. At September 30, 2020, outstanding balance of the loan are current. | |||
[2] | Our revolving credit facility is collateralized by our accounts receivable and our term loan is collateralized by our property, plant, and equipment. Effective July 1, 2019, monthly installment principal payment on the Term Loan was amended to approximately $35,500 from approximately $101,600. See "Revolving Credit and Term Loan Agreement" below for terms of the Company's credit facility prior to the New Loan Agreement dated May 8, 2020. | |||
[3] | Net of debt issuance costs of ($113,000) and ($92,000) at September 30, 2020 and December 31, 2019, respectively. | |||
[4] | Uncollateralized note. | |||
[5] | Entered into with the Company's credit facility lender under the Paycheck Protection Program (see "PPP Loan" below for further information on this loan). |
Long Term Debt - Schedule of _2
Long Term Debt - Schedule of Long term Debt (Details) (Parenthetical) - USD ($) | May 08, 2020 | Apr. 14, 2020 | Apr. 02, 2020 | Jul. 02, 2019 | Sep. 30, 2020 | Dec. 31, 2019 | Jun. 10, 2020 |
Debt issuance costs net | $ (113,000) | $ (92,000) | |||||
Debt discount including debt issuance | (99,000) | (248,000) | |||||
Prepayments in principal amount | 416,000 | $ 520,000 | |||||
Repayments of loan debt | $ 1,457,000 | ||||||
Promissory Note [Member] | |||||||
Effective interest rate | 4.00% | ||||||
Principal amount | $ 208,000 | ||||||
Promissory Note [Member] | |||||||
Debt due date | Apr. 14, 2022 | ||||||
Effective interest rate | 1.00% | ||||||
Note Payable [Member] | |||||||
Effective interest rate | 5.64% | ||||||
Revolving Credit [Member] | |||||||
Debt due date | May 15, 2024 | ||||||
Effective interest rate | 6.10% | ||||||
Term Loan [Member] | |||||||
Debt due date | May 15, 2024 | ||||||
Effective interest rate | 5.50% | ||||||
Principal amount | $ 101,600 | ||||||
Amended Term Loan [Member] | |||||||
Principal amount | $ 35,500 |
Commitments and Contingencies (
Commitments and Contingencies (Details Narrative) - USD ($) $ in Thousands | 1 Months Ended | 3 Months Ended | 9 Months Ended | ||||
Jul. 30, 2020 | Jun. 30, 2003 | Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | Dec. 31, 2019 | |
Self-insured retention | $ 100,000 | ||||||
Finite risk sinking fund (restricted cash) | $ 11,418 | $ 11,418 | $ 11,307 | ||||
Interest income, other | 28 | $ 77 | 112 | $ 265 | |||
Letters of credit outstanding, amount | 3,026 | 3,026 | |||||
Bond outstanding | 45,814 | 45,814 | |||||
American International Group, Inc [Member] | |||||||
Period of finite risk insurance policy | 25 years | ||||||
Maximum allowable coverage of insurance policy | $ 28,177 | ||||||
Coverage amount under the policy | 19,651 | 19,651 | |||||
Interest earned on sinking fund | 1,947 | 1,947 | $ 1,836 | ||||
Interest income, other | $ 28 | $ 77 | $ 111 | $ 265 | |||
Insurers obligation to entity on termination of contract | 100.00% | 100.00% |
Discontinued Operations (Detail
Discontinued Operations (Details Narrative) - USD ($) | 1 Months Ended | 3 Months Ended | 9 Months Ended | |||
May 31, 2016 | Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | Jul. 24, 2020 | |
Loss from discontinued operations, net of taxes of $0 | $ (67,000) | $ (156,000) | $ (266,000) | $ (424,000) | ||
Tax effect of discontinued operation | $ 0 | $ 0 | $ 0 | $ 0 | ||
Perma-Fix of Michigan, Inc. [Member] | ||||||
Disposal group, including discontinued operation, consideration, after closing | $ 375,000 | |||||
Disposal group, including discontinued operation, consideration, installment payment | $ 7,250 | |||||
Disposal group, including discontinued operation, consideration, remaining balance | $ 105,000 |
Discontinued Operations - Sched
Discontinued Operations - Schedule of Disposal Groups, Including Discontinued Operation Balance Sheet (Details) - USD ($) $ in Thousands | Sep. 30, 2020 | Dec. 31, 2019 | |
Discontinued Operations and Disposal Groups [Abstract] | |||
Other assets | $ 17 | $ 104 | |
Total current assets | 17 | 104 | |
Property, plant and equipment, net | [1] | 81 | 81 |
Other assets | 36 | ||
Total long-term assets | 81 | 117 | |
Total assets | 98 | 221 | |
Accounts payable | 8 | 8 | |
Accrued expenses and other liabilities | 167 | 169 | |
Environmental liabilities | 744 | 817 | |
Total current liabilities | 919 | 994 | |
Closure liabilities | 140 | 134 | |
Environmental liabilities | 110 | 110 | |
Total long-term liabilities | 250 | 244 | |
Total liabilities | $ 1,169 | $ 1,238 | |
[1] | Net of accumulated depreciation of $10,000 for each period presented. |
Discontinued Operations - Sch_2
Discontinued Operations - Schedule of Disposal Groups, Including Discontinued Operation Balance Sheet (Details) (Parenthetical) - USD ($) $ in Thousands | 9 Months Ended | 12 Months Ended |
Sep. 30, 2020 | Dec. 31, 2019 | |
Discontinued Operations and Disposal Groups [Abstract] | ||
Accumulated depreciation | $ 10 | $ 10 |
Operating Segments (Details Nar
Operating Segments (Details Narrative) | 9 Months Ended |
Sep. 30, 2020Integer | |
Segment Reporting [Abstract] | |
Number of reportable segments | 3 |
Operating Segments - Schedule o
Operating Segments - Schedule of Segment Reporting Information (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||||||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | ||||||
Revenue from external customers | $ 30,172 | $ 22,535 | $ 77,079 | $ 51,378 | |||||
Intercompany revenues | |||||||||
Gross profit | 4,750 | 5,157 | 12,700 | 10,929 | |||||
Research and development | 157 | 165 | 598 | 615 | |||||
Interest income | 28 | 77 | 112 | 265 | |||||
Interest expense | (87) | (99) | (306) | (293) | |||||
Interest expense-financing fees | (58) | (69) | (187) | (139) | |||||
Depreciation and amortization | 478 | 328 | 1,189 | 968 | |||||
Segment income (loss) before income taxes | 1,348 | 1,950 | 2,921 | 1,818 | |||||
Income tax (benefit) expense | (133) | 55 | (128) | 99 | |||||
Segment income (loss) | 1,481 | 1,895 | 3,049 | 1,719 | |||||
Expenditures for segment assets | 122 | [1] | 501 | [2] | 1,488 | [1] | 813 | [2] | |
Treatment [Member] | |||||||||
Revenue from external customers | 7,066 | 10,081 | 24,469 | 30,079 | |||||
Intercompany revenues | 226 | 75 | 879 | 83 | |||||
Gross profit | 1,094 | 3,338 | 5,533 | 8,921 | |||||
Research and development | 49 | 85 | 194 | 367 | |||||
Interest income | 1 | ||||||||
Interest expense | (34) | (19) | (80) | (66) | |||||
Interest expense-financing fees | |||||||||
Depreciation and amortization | 373 | 243 | 912 | 713 | |||||
Segment income (loss) before income taxes | 280 | 2,244 | 2,577 | 5,731 | |||||
Income tax (benefit) expense | (170) | 55 | (165) | 99 | |||||
Segment income (loss) | 450 | 2,189 | 2,742 | 5,632 | |||||
Expenditures for segment assets | 95 | 470 | 1,095 | 764 | |||||
Services [Member] | |||||||||
Revenue from external customers | 23,106 | 12,454 | 52,610 | 21,299 | |||||
Intercompany revenues | 6 | 38 | 19 | 101 | |||||
Gross profit | 3,656 | 1,819 | 7,167 | 2,008 | |||||
Research and development | 7 | 119 | |||||||
Interest income | |||||||||
Interest expense | (3) | (5) | (13) | (18) | |||||
Interest expense-financing fees | |||||||||
Depreciation and amortization | 97 | 79 | 259 | 236 | |||||
Segment income (loss) before income taxes | 2,813 | 1,193 | 5,162 | 318 | |||||
Income tax (benefit) expense | 2 | 2 | |||||||
Segment income (loss) | 2,811 | 1,193 | 5,160 | 318 | |||||
Expenditures for segment assets | 24 | 31 | 385 | 49 | |||||
Medical [Member] | |||||||||
Revenue from external customers | |||||||||
Intercompany revenues | |||||||||
Gross profit | |||||||||
Research and development | 81 | 74 | 221 | 228 | |||||
Interest income | |||||||||
Interest expense | |||||||||
Interest expense-financing fees | |||||||||
Depreciation and amortization | |||||||||
Segment income (loss) before income taxes | (81) | (74) | (221) | (228) | |||||
Income tax (benefit) expense | |||||||||
Segment income (loss) | (81) | (74) | (221) | (228) | |||||
Expenditures for segment assets | |||||||||
Segments Total [Member] | |||||||||
Revenue from external customers | 30,172 | 22,535 | 77,079 | 51,378 | |||||
Intercompany revenues | 232 | 113 | 898 | 184 | |||||
Gross profit | 4,750 | 5,157 | 12,700 | 10,929 | |||||
Research and development | 137 | 159 | 534 | 595 | |||||
Interest income | 1 | ||||||||
Interest expense | (37) | (24) | (93) | (84) | |||||
Interest expense-financing fees | |||||||||
Depreciation and amortization | 470 | 322 | 1,171 | 949 | |||||
Segment income (loss) before income taxes | 3,012 | 3,363 | 7,518 | 5,821 | |||||
Income tax (benefit) expense | (168) | 55 | (163) | 99 | |||||
Segment income (loss) | 3,180 | 3,308 | 7,681 | 5,722 | |||||
Expenditures for segment assets | 119 | 501 | 1,480 | 813 | |||||
Corporate [Member] | |||||||||
Revenue from external customers | [3] | ||||||||
Intercompany revenues | [3] | ||||||||
Gross profit | [3] | ||||||||
Research and development | [3] | 20 | 6 | 64 | 20 | ||||
Interest income | [3] | 28 | 77 | 111 | 265 | ||||
Interest expense | [3] | (50) | (75) | (213) | (209) | ||||
Interest expense-financing fees | [3] | (58) | (69) | (187) | (139) | ||||
Depreciation and amortization | [3] | 8 | 6 | 18 | 19 | ||||
Segment income (loss) before income taxes | [3] | (1,664) | (1,413) | (4,597) | (4,003) | ||||
Income tax (benefit) expense | [3] | 35 | 35 | ||||||
Segment income (loss) | [3] | (1,699) | (1,413) | (4,632) | (4,003) | ||||
Expenditures for segment assets | [3] | $ 3 | $ 8 | ||||||
[1] | Net of financed amount of $751,000 and $883,000 for the three and nine months ended September 30, 2020, respectively. | ||||||||
[2] | Net of financed amount of $6,000 and $29,000 for the three and nine months ended September 30, 2019, respectively. | ||||||||
[3] | Amounts reflect the activity for corporate headquarters not included in the segment information. |
Operating Segments - Schedule_2
Operating Segments - Schedule of Segment Reporting Information (Details) (Parenthetical) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Segment Reporting [Abstract] | ||||
Net of financed amount | $ 751 | $ 6 | $ 883 | $ 29 |
Income Taxes (Details Narrative
Income Taxes (Details Narrative) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Income Tax Disclosure [Abstract] | ||||
Income tax (benefit) expense | $ (133) | $ 55 | $ (128) | $ 99 |
Effective income tax rate reconciliation, percent | 9.90% | 2.80% | 4.40% | 5.40% |
Variable Interest Entities (V_2
Variable Interest Entities (VIE) (Details Narrative) - USD ($) $ in Thousands | May 24, 2019 | Sep. 30, 2020 | Dec. 31, 2019 |
Partnership interest rate | 51.00% | ||
Total assets | $ 79,481 | $ 66,515 | |
Total liabilities | 47,169 | $ 37,279 | |
Engineering/Remediation Resources Group, Inc [Member] | |||
Partnership interest rate | 49.00% | ||
Perma-Fix ERRG [Member] | |||
Total assets | 5,302 | ||
Total liabilities | $ 5,302 |
Deferral of Employment Tax De_2
Deferral of Employment Tax Deposits (Details Narrative) - USD ($) | 1 Months Ended | |
Sep. 30, 2020 | Dec. 31, 2019 | |
Other long-term liabilities | $ 838,000 | |
Deferral of Employment Tax Deposits [Member] | ||
Remaining payment of social security taxes amount | $ 1,225,000 | |
Social security taxes deferred description | The CARES Act, as amended by the Flexibility Act which was signed into law on June 5, 2020, provides employers the option to defer the payment of an employer's share of social security taxes beginning on March 27, 2020 through December 31, 2020 with 50% of the amount of social security taxes deferred to become due on December 31, 2021 with the remaining 50% due on December 31, 2022. The Company elected to defer such taxes starting in mid-April 2020. The Company estimates the remaining payment of approximately $1,225,000 of social security taxes otherwise due in 2020 will be deferred with 50% due by December 31, 2021 and the remaining 50% due by December 31, 2022. | |
Deferral of Employment Tax Deposits [Member] | December 31, 2021 [Member] | ||
Percentage of social security taxes deferred payable | 50.00% | |
Deferral of Employment Tax Deposits [Member] | December 31, 2022 [Member] | ||
Percentage of social security taxes deferred payable | 50.00% |
Employment Agreements and Man_2
Employment Agreements and Management Incentive Plan (MIP) (Details Narrative) - Richard Grondin [Member] - USD ($) | Jul. 22, 2020 | Jul. 21, 2020 |
Annual salary | $ 208,000 | |
New Employment Agreements [Member] | ||
Annual salary | $ 240,000 | |
Waste Treatment Operations Employment Agreement [Member] | Minimum [Member] | ||
Potential target performance compensation of base salary, percentage | 5.00% | |
Base salary of performance compensation | $ 12,000 | |
Waste Treatment Operations Employment Agreement [Member] | Maximum [Member] | ||
Potential target performance compensation of base salary, percentage | 100.00% | |
Base salary of performance compensation | $ 240,000 |